blog.visiblealpha.com Open in urlscan Pro
2606:2c40::c73c:671c Public Scan

Go To Rescan
Add Verdict Report

URL:
https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Submission: On March 26 via api (March 26th 2023, 4:10:39 pm UTC) from CH — Scanned from DE

Summary HTTP 98 Redirects Links 52 Behaviour Indicators

Summary

This website contacted 38 IPs in 3 countries across 31 domains to perform 98 HTTP transactions. The main IP is 2606:2c40::c73c:671c, located in United States and belongs to CLOUDFLARESPECTRUM Cloudflare, Inc., US. The main domain is blog.visiblealpha.com.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on June 15th 2022. Valid for: a year.

This is the only time blog.visiblealpha.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
29	2606:2c40::c7... 2606:2c40::c73c:671c	209242 (CLOUDFLAR...) (CLOUDFLARESPECTRUM Cloudflare)
1	2a02:26f0:480... 2a02:26f0:480:e::210:f113	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
1	2606:4700::68... 2606:4700::6811:f4cc	13335 (CLOUDFLAR...) (CLOUDFLARENET)
5	2606:4700:440... 2606:4700:4400::ac40:9ad8	13335 (CLOUDFLAR...) (CLOUDFLARENET)
10	2606:4700::68... 2606:4700::6813:9b53	13335 (CLOUDFLAR...) (CLOUDFLARENET)
3	2606:4700::68... 2606:4700::6811:180e	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6810:5714	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2 4	2606:4700::68... 2606:4700::6810:7daf	13335 (CLOUDFLAR...) (CLOUDFLARENET)
4	2606:4700::68... 2606:4700::6810:a852	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2a00:1450:400... 2a00:1450:4001:806::2002	15169 (GOOGLE) (GOOGLE)
3	2a00:1450:400... 2a00:1450:4001:813::200a	15169 (GOOGLE) (GOOGLE)
3	2a00:1450:400... 2a00:1450:4001:811::2003	15169 (GOOGLE) (GOOGLE)
2	2606:4700::68... 2606:4700::6812:acf	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	2606:2800:234... 2606:2800:234:59:254c:406:2366:268c	15133 (EDGECAST) (EDGECAST)
1	2606:4700::68... 2606:4700::6811:cccc	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6811:47b0	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6811:eacc	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700:440... 2606:4700:4400::6812:21ab	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	104.244.42.200 104.244.42.200	13414 (TWITTER) (TWITTER)
1	2606:4700::68... 2606:4700::6810:5605	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6810:5805	13335 (CLOUDFLAR...) (CLOUDFLARENET)
3	2606:4700::68... 2606:4700::6810:5705	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2a00:1450:400... 2a00:1450:4001:813::2008	15169 (GOOGLE) (GOOGLE)
2	2a00:1450:400... 2a00:1450:4001:810::200e	15169 (GOOGLE) (GOOGLE)
1	2a02:26f0:480... 2a02:26f0:480:e::210:f108	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
1	146.75.116.157 146.75.116.157	54113 (FASTLY) (FASTLY)
4	3.219.162.91 3.219.162.91	14618 (AMAZON-AES) (AMAZON-AES)
1	13.32.121.18 13.32.121.18	16509 (AMAZON-02) (AMAZON-02)
1	2600:9000:225... 2600:9000:225e:3c00:1f:f723:6fc0:93a1	16509 (AMAZON-02) (AMAZON-02)
1	104.244.42.133 104.244.42.133	13414 (TWITTER) (TWITTER)
1	104.244.42.3 104.244.42.3	13414 (TWITTER) (TWITTER)
1	13.32.99.98 13.32.99.98	16509 (AMAZON-02) (AMAZON-02)
1	2a00:1450:400... 2a00:1450:400c:c07::9d	15169 (GOOGLE) (GOOGLE)
1	2600:9000:20e... 2600:9000:20eb:f200:2:53b2:240:93a1	16509 (AMAZON-02) (AMAZON-02)
3 3	2620:1ec:21::14 2620:1ec:21::14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
1	13.107.42.14 13.107.42.14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
1	2a00:1450:400... 2a00:1450:4001:813::2004	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:80b::2003	15169 (GOOGLE) (GOOGLE)
2	52.202.168.65 52.202.168.65	14618 (AMAZON-AES) (AMAZON-AES)
98	38

29 2606:2c40::c73c:671c (United States)

ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US)

blog.visiblealpha.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a02:26f0:480:e::210:f113 (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1, NL)

platform.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6811:f4cc (United States)

ASN13335 (CLOUDFLARENET, US)

cdn2.hubspot.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2606:4700:4400::ac40:9ad8 (United States)

ASN13335 (CLOUDFLARENET, US)

2355593.fs1.hubspotusercontent-na1.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

10 2606:4700::6813:9b53 (United States)

ASN13335 (CLOUDFLARENET, US)

no-cache.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
app.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
cta-service-cms2.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
track.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
forms.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2606:4700::6811:180e (United States)

ASN13335 (CLOUDFLARENET, US)

cdnjs.cloudflare.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:5714 (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.jsdelivr.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2606:4700::6810:7daf (United States) 2 redirects

ASN13335 (CLOUDFLARENET, US)

unpkg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2606:4700::6810:a852 (United States)

ASN13335 (CLOUDFLARENET, US)

ws.zoominfo.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:806::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

pubads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:813::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:811::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2606:4700::6812:acf (United States)

ASN13335 (CLOUDFLARENET, US)

stackpath.bootstrapcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2606:2800:234:59:254c:406:2366:268c (United States)

ASN15133 (EDGECAST, US)

platform.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6811:cccc (United States)

ASN13335 (CLOUDFLARENET, US)

api-na1.hubapi.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6811:47b0 (United States)

ASN13335 (CLOUDFLARENET, US)

js.hs-analytics.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6811:eacc (United States)

ASN13335 (CLOUDFLARENET, US)

js.hsleadflows.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:4400::6812:21ab (United States)

ASN13335 (CLOUDFLARENET, US)

js.hs-banner.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.244.42.200 (United States)

ASN13414 (TWITTER, US)

syndication.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:5605 (United States)

ASN13335 (CLOUDFLARENET, US)

forms.hsforms.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:5805 (United States)

ASN13335 (CLOUDFLARENET, US)

forms-na1.hsforms.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2606:4700::6810:5705 (United States)

ASN13335 (CLOUDFLARENET, US)

perf.hsforms.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:813::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:810::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a02:26f0:480:e::210:f108 (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1, NL)

snap.licdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 146.75.116.157 (Frankfurt am Main, Germany)

ASN54113 (FASTLY, US)

static.ads-twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 3.219.162.91 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-219-162-91.compute-1.amazonaws.com

tags.srv.stackadapt.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.32.121.18 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-13-32-121-18.fra60.r.cloudfront.net

assets.rampmetrics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:225e:3c00:1f:f723:6fc0:93a1 (United States)

ASN16509 (AMAZON-02, US)

sc.lfeeder.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.244.42.133 (United States)

ASN13414 (TWITTER, US)

t.co	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.244.42.3 (United States)

ASN13414 (TWITTER, US)

analytics.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.32.99.98 (United States)

ASN16509 (AMAZON-02, US)
PTR: server-13-32-99-98.fra60.r.cloudfront.net

tr-rc.lfeeder.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:400c:c07::9d (Brussels, Belgium)

ASN15169 (GOOGLE, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:20eb:f200:2:53b2:240:93a1 (United States)

ASN16509 (AMAZON-02, US)

cdn.linkedin.oribi.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2620:1ec:21::14 (United States) 3 redirects

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.107.42.14 (United States)

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px4.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:813::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:80b::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.202.168.65 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-52-202-168-65.compute-1.amazonaws.com

events.rm-api.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
29	visiblealpha.com blog.visiblealpha.com	2 MB
10	hubspot.com no-cache.hubspot.com — Cisco Umbrella Rank: 10314 app.hubspot.com — Cisco Umbrella Rank: 5240 cta-service-cms2.hubspot.com — Cisco Umbrella Rank: 9730 track.hubspot.com — Cisco Umbrella Rank: 2028 forms.hubspot.com — Cisco Umbrella Rank: 4142	273 KB
5	hsforms.com forms.hsforms.com — Cisco Umbrella Rank: 3742 forms-na1.hsforms.com — Cisco Umbrella Rank: 6056 perf.hsforms.com — Cisco Umbrella Rank: 10823	3 KB
5	hubspotusercontent-na1.net 2355593.fs1.hubspotusercontent-na1.net	375 KB
5	linkedin.com 3 redirects platform.linkedin.com — Cisco Umbrella Rank: 2973 px.ads.linkedin.com — Cisco Umbrella Rank: 326 www.linkedin.com — Cisco Umbrella Rank: 555 px4.ads.linkedin.com — Cisco Umbrella Rank: 6206	163 KB
4	stackadapt.com tags.srv.stackadapt.com — Cisco Umbrella Rank: 2877	8 KB
4	twitter.com platform.twitter.com — Cisco Umbrella Rank: 758 syndication.twitter.com — Cisco Umbrella Rank: 1090 analytics.twitter.com — Cisco Umbrella Rank: 618	132 KB
4	zoominfo.com ws.zoominfo.com — Cisco Umbrella Rank: 4441	4 KB
4	unpkg.com 2 redirects unpkg.com — Cisco Umbrella Rank: 772	13 KB
3	gstatic.com fonts.gstatic.com	137 KB
3	googleapis.com fonts.googleapis.com — Cisco Umbrella Rank: 31	3 KB
3	cloudflare.com cdnjs.cloudflare.com — Cisco Umbrella Rank: 194	12 KB
2	rm-api.com events.rm-api.com — Cisco Umbrella Rank: 180904	327 B
2	lfeeder.com sc.lfeeder.com — Cisco Umbrella Rank: 13248 tr-rc.lfeeder.com — Cisco Umbrella Rank: 17818	11 KB
2	google-analytics.com www.google-analytics.com — Cisco Umbrella Rank: 25	20 KB
2	bootstrapcdn.com stackpath.bootstrapcdn.com — Cisco Umbrella Rank: 2339	83 KB
2	doubleclick.net pubads.g.doubleclick.net — Cisco Umbrella Rank: 455 stats.g.doubleclick.net — Cisco Umbrella Rank: 70	895 B
1	google.de www.google.de — Cisco Umbrella Rank: 6058	408 B
1	google.com www.google.com — Cisco Umbrella Rank: 2	408 B
1	oribi.io cdn.linkedin.oribi.io — Cisco Umbrella Rank: 797	368 B
1	t.co t.co — Cisco Umbrella Rank: 507	378 B
1	rampmetrics.com assets.rampmetrics.com — Cisco Umbrella Rank: 197276	38 KB
1	ads-twitter.com static.ads-twitter.com — Cisco Umbrella Rank: 616	15 KB
1	licdn.com snap.licdn.com — Cisco Umbrella Rank: 685	5 KB
1	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 39	64 KB
1	hs-banner.com js.hs-banner.com — Cisco Umbrella Rank: 1934	16 KB
1	hsleadflows.net js.hsleadflows.net — Cisco Umbrella Rank: 3966	87 KB
1	hs-analytics.net js.hs-analytics.net — Cisco Umbrella Rank: 1926	21 KB
1	hubapi.com api-na1.hubapi.com — Cisco Umbrella Rank: 20631	718 B
1	jsdelivr.net cdn.jsdelivr.net — Cisco Umbrella Rank: 334	11 KB
1	hubspot.net cdn2.hubspot.net — Cisco Umbrella Rank: 7428	2 KB
98	31

	Domain	Requested by
29	blog.visiblealpha.com	blog.visiblealpha.com
6	track.hubspot.com
5	2355593.fs1.hubspotusercontent-na1.net	blog.visiblealpha.com
4	tags.srv.stackadapt.com	blog.visiblealpha.com tags.srv.stackadapt.com
4	ws.zoominfo.com	blog.visiblealpha.com ws.zoominfo.com
4	unpkg.com	2 redirects blog.visiblealpha.com
3	perf.hsforms.com	blog.visiblealpha.com
3	fonts.gstatic.com	fonts.googleapis.com
3	fonts.googleapis.com	blog.visiblealpha.com
3	cdnjs.cloudflare.com	blog.visiblealpha.com
2	events.rm-api.com	assets.rampmetrics.com
2	px.ads.linkedin.com	2 redirects
2	www.google-analytics.com	www.googletagmanager.com www.google-analytics.com
2	platform.twitter.com	blog.visiblealpha.com platform.twitter.com
2	stackpath.bootstrapcdn.com	blog.visiblealpha.com stackpath.bootstrapcdn.com
1	forms.hubspot.com	js.hsleadflows.net
1	www.google.de	blog.visiblealpha.com
1	www.google.com	blog.visiblealpha.com
1	px4.ads.linkedin.com	blog.visiblealpha.com
1	www.linkedin.com	1 redirects
1	cdn.linkedin.oribi.io	snap.licdn.com
1	stats.g.doubleclick.net	www.google-analytics.com
1	tr-rc.lfeeder.com	blog.visiblealpha.com
1	analytics.twitter.com	blog.visiblealpha.com
1	t.co	blog.visiblealpha.com
1	sc.lfeeder.com	blog.visiblealpha.com
1	assets.rampmetrics.com	blog.visiblealpha.com
1	static.ads-twitter.com	www.googletagmanager.com
1	snap.licdn.com	www.googletagmanager.com
1	www.googletagmanager.com	blog.visiblealpha.com
1	forms-na1.hsforms.com	blog.visiblealpha.com
1	forms.hsforms.com	blog.visiblealpha.com
1	syndication.twitter.com	platform.twitter.com
1	js.hs-banner.com	blog.visiblealpha.com
1	js.hsleadflows.net	blog.visiblealpha.com
1	js.hs-analytics.net	blog.visiblealpha.com
1	cta-service-cms2.hubspot.com	blog.visiblealpha.com
1	api-na1.hubapi.com	blog.visiblealpha.com
1	app.hubspot.com	blog.visiblealpha.com
1	pubads.g.doubleclick.net	blog.visiblealpha.com
1	cdn.jsdelivr.net	blog.visiblealpha.com
1	no-cache.hubspot.com	blog.visiblealpha.com
1	cdn2.hubspot.net	blog.visiblealpha.com
1	platform.linkedin.com	blog.visiblealpha.com
98	44

This site contains links to these domains. Also see Links.

Domain
visiblealpha.com
www.visiblealpha.com
news.visiblealpha.com
insights.visiblealpha.com
2355593.fs1.hubspotusercontent-na1.net
www.fda.gov
twitter.com
www.facebook.com
www.linkedin.com

Subject Issuer	Validity	Valid
blog.visiblealpha.com Cloudflare Inc ECC CA-3	`2022-06-15` - `2023-06-15`	a year	crt.sh
platform.linkedin.com DigiCert SHA2 Secure Server CA	`2022-06-09` - `2023-06-09`	a year	crt.sh
hubspot.net Cloudflare Inc ECC CA-3	`2022-05-06` - `2023-05-06`	a year	crt.sh
hubspotusercontent-na1.net Cloudflare Inc ECC CA-3	`2023-01-26` - `2024-01-25`	a year	crt.sh
hubspot.com Cloudflare Inc ECC CA-3	`2023-02-05` - `2024-02-05`	a year	crt.sh
sni.cloudflaressl.com Cloudflare Inc ECC CA-3	`2022-08-03` - `2023-08-02`	a year	crt.sh
zoominfo.com Cloudflare Inc ECC CA-3	`2023-03-22` - `2024-03-21`	a year	crt.sh
*.g.doubleclick.net GTS CA 1C3	`2023-03-06` - `2023-05-29`	3 months	crt.sh
upload.video.google.com GTS CA 1C3	`2023-03-06` - `2023-05-29`	3 months	crt.sh
*.gstatic.com GTS CA 1C3	`2023-03-06` - `2023-05-29`	3 months	crt.sh
*.twimg.com DigiCert TLS RSA SHA256 2020 CA1	`2022-10-06` - `2023-11-06`	a year	crt.sh
hubapi.com Cloudflare Inc ECC CA-3	`2022-05-07` - `2023-05-07`	a year	crt.sh
syndication.twitter.com DigiCert TLS Hybrid ECC SHA384 2020 CA1	`2023-02-05` - `2024-02-05`	a year	crt.sh
*.google-analytics.com GTS CA 1C3	`2023-03-06` - `2023-05-29`	3 months	crt.sh
snap.licdn.com DigiCert SHA2 Secure Server CA	`2023-02-01` - `2024-01-31`	a year	crt.sh
ads-twitter.com DigiCert TLS RSA SHA256 2020 CA1	`2022-07-22` - `2023-08-22`	a year	crt.sh
*.srv.stackadapt.com Amazon RSA 2048 M02	`2023-02-27` - `2023-11-07`	8 months	crt.sh
*.rampmetrics.com Sectigo ECC Domain Validation Secure Server CA	`2023-02-16` - `2024-03-18`	a year	crt.sh
*.lfeeder.com Amazon RSA 2048 M01	`2023-02-28` - `2023-08-07`	5 months	crt.sh
t.co DigiCert TLS Hybrid ECC SHA384 2020 CA1	`2023-02-05` - `2024-02-05`	a year	crt.sh
*.twitter.com DigiCert TLS Hybrid ECC SHA384 2020 CA1	`2023-02-05` - `2024-02-05`	a year	crt.sh
linkedin.oribi.io Amazon RSA 2048 M01	`2023-02-24` - `2023-08-06`	5 months	crt.sh
www.google.com GTS CA 1C3	`2023-03-06` - `2023-05-29`	3 months	crt.sh
www.google.de GTS CA 1C3	`2023-03-06` - `2023-05-29`	3 months	crt.sh
events.rm-api.com R3	`2023-03-13` - `2023-06-11`	3 months	crt.sh

This page contains 2 frames:

Primary Page: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Frame ID: C8E3CA9B7BC98C41119F400D13784070
Requests: 94 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html?origin=https%3A%2F%2Fblog.visiblealpha.com
Frame ID: 1FA32C781CA6831EEE745C26C424A2AA
Requests: 2 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

FDA Drug Approvals in 2022 | Visible Alpha

Detected technologies

AMP (JavaScript frameworks) Expand

Overall confidence: 100%
Detected patterns

<link rel="amphtml"

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

google-analytics\.com/(?:ga|urchin|analytics)\.js

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtm\.js

HubSpot Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

js\.hs-analytics\.net/analytics

Linkedin (Widgets) Expand

Overall confidence: 100%
Detected patterns

//platform\.linkedin\.com/in\.js

Linkedin Insight Tag (Analytics) Expand

Overall confidence: 100%
Detected patterns

snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

Slick (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

(?:/([\d.]+))?/slick(?:\.min)?\.js

Twitter (Widgets) Expand

Overall confidence: 100%
Detected patterns

//platform\.twitter\.com/widgets\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]([\d.]*\d)[^/]*\.js
jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

jsDelivr (CDN) Expand

Overall confidence: 100%
Detected patterns

//cdn\.jsdelivr\.net/

Page Statistics

98
Requests

97 %
HTTPS

77 %
IPv6

31
Domains

44
Subdomains

38
IPs

3
Countries

3259 kB
Transfer

5552 kB
Size

31
Cookies

52 Outgoing links

These are links going to different origins than the main page.

URL: https://visiblealpha.com/privacy-policy
Title: privacy policy.

Search URL Search Domain Scan URL

URL: http://www.visiblealpha.com/

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/
Title: Solutions

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/buy-side/
Title: Buy-Side

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/buy-side-analyst/
Title: Buy-Side Analyst

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/portfolio-manager/
Title: Portfolio Manager

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/quantitative-researcher/
Title: Quantitative Researcher

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/sell-side/
Title: Sell Side

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/equity-research-analyst/
Title: Equity Research Analyst

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/director-research/
Title: Director of Research

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/sell-side-equity-sales/
Title: Equity Sales

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/investment-banker/
Title: Investment Banker

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/corporates/
Title: Corporates

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/corporate-strategy/
Title: Corporate Strategy

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/investor-relations/
Title: Investor Relations

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/other-industries/
Title: Other Industries

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/academics/
Title: Academics

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/consultants/
Title: Consultants

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/business-reporter/
Title: Business Reporter

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/alternative-data-firm/
Title: Alternative Data Firm

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/products/
Title: Products

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/products/consensus-estimates-for-investment-research/
Title: Insights – Consensus Estimates for Investment Research

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/products/corporate-insights/
Title: Corporate Insights

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/products/consensus-estimates-apis-feeds/
Title: Consensus Estimates through APIs and Feeds

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/services/
Title: Services

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/brokers/
Title: Brokers

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/about-us/
Title: About Us

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/leadership-team/
Title: Leadership

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/careers/
Title: Careers

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/awards/
Title: Awards

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/events/
Title: Events

Search URL Search Domain Scan URL

URL: https://news.visiblealpha.com/
Title: News

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/solutions/media-kit/
Title: Media Kit

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/resources/
Title: Resources

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/consensus-estimates/
Title: Industry Consensus Estimates

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/kpi-guides/
Title: KPI Guides

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/resources-by-industry/
Title: Resources by Industry

Search URL Search Domain Scan URL

URL: https://insights.visiblealpha.com/login
Title: Login

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/get-started/
Title: Get Started

Search URL Search Domain Scan URL

URL: https://2355593.fs1.hubspotusercontent-na1.net/hubfs/2355593/VA-Doc-FDA%20Approved%20Drugs%202022%20%26%20Select%20Consensus%20Revs-031723%20(3).pdf
Title: Table 2

Search URL Search Domain Scan URL

URL: https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022)
Title: (https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022)

Search URL Search Domain Scan URL

URL: https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/2022-biological-license-application-approvals)
Title: (https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/2022-biological-license-application-approvals)

Search URL Search Domain Scan URL

URL: https://twitter.com/intent/tweet?original_referer=&url=&source=tweetbutton&text=

Search URL Search Domain Scan URL

URL: https://www.facebook.com/sharer/sharer.php?u=https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/shareArticle?mini=true&url=https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making&title=&summary=&source=

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/privacy-policy/
Title: Privacy Policy

Search URL Search Domain Scan URL

URL: https://www.facebook.com/visiblealpha/
Title: Facebook

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/visible-alpha/
Title: LinkedIn

Search URL Search Domain Scan URL

URL: https://twitter.com/VisibleAlpha
Title: Twitter

Search URL Search Domain Scan URL

URL: http://visiblealpha.com/careers/
Title: Careers

Search URL Search Domain Scan URL

URL: http://visiblealpha.com/privacy-policy/
Title: Privacy Policy

Search URL Search Domain Scan URL

URL: https://visiblealpha.com/terms-of-use/
Title: Terms of Use

Search URL Search Domain Scan URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 25

https://unpkg.com/imagesloaded@4/imagesloaded.pkgd.min.js HTTP 302
https://unpkg.com/imagesloaded@4.1.4/imagesloaded.pkgd.min.js

Request Chain 26

https://unpkg.com/isotope-layout@3.0/dist/isotope.pkgd.min.js HTTP 302
https://unpkg.com/isotope-layout@3.0.6/dist/isotope.pkgd.min.js

Request Chain 77

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making HTTP 302
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D546794%26time%3D1679847033443%26url%3Dhttps%253A%252F%252Fblog.visiblealpha.com%252Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making%26liSync%3Dtrue HTTP 302
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&liSync=true HTTP 302
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&liSync=true&e_ipv6=AQL6jV7sXzTNpQAAAYcer4uuE_YogXv-KCqyC9vAUc2Q9N45SXB_hApDIJ7aAiGGGDXMqoDXohYWwe-tBhndG4dee7DGWQ

98 HTTP transactions
0 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2 200 Primary Request fda-drug-approvals-in-2022-several-blockbusters-in-the-making Show response
blog.visiblealpha.com/ 72 KB
17 KB 787ms
710ms Document
text/html 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

d236856f4b95b7083e160195e7a0c74d63f4a2a2e7d2e0e1878caa5e89ec6318

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests
Strict-Transport-Security	max-age=31536000

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
cache-control: s-maxage=10800, max-age=0
cf-ray: 7ae0aa09b95d997a-FRA
content-encoding: br
content-security-policy: upgrade-insecure-requests
content-type: text/html; charset=UTF-8
date: Sun, 26 Mar 2023 16:10:32 GMT
edge-cache-tag: CT-106512198193,CG-4226313608,P-2355593,L-5688227683,L-5688521181,L-6297012270,W-39285831626,W-5688952001,CW-56804756318,CW-5688827902,CW-6297077538,E-5678766005,E-5688521176,E-5688521177,E-6297554256,E-6335810317,E-6834941253,MENU-39285831626,MENU-5688952001,PGS-ALL,SW-4,B-4226313608,GC-70740492349
etag: W/"e85e80c971418baf1dc4e54f645cdb6b"
last-modified: Sat, 25 Mar 2023 22:02:21 GMT
link: </hs/hsstatic/AsyncSupport/static-1.122/js/comment_listing_asset.js>; rel=preload; as=script,</hs/hsstatic/keyboard-accessible-menu-flyouts/static-1.17/bundles/project.js>; rel=preload; as=script,</hs/hsstatic/HubspotToolsMenu/static-1.154/js/index.js>; rel=preload; as=script,</hs/hsstatic/cos-i18n/static-1.53/bundles/project.js>; rel=preload; as=script,</_hcms/forms/v2.js>; rel=preload; as=script
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
referrer-policy: no-referrer-when-downgrade
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Ppp%2BEWan6j%2F3Lz4gAHwTfiBeUX8ZabKUwqsRd%2FUpBikyn949AxlU5k7ePlOYBfpXcKmqs54T4WNc1UZQQYToJE%2B%2BbfKGmIZLguLsSR5V%2FI4poLDQkeull2iHdqNY48DRYXc4IA19sXZty3ddzavD0DoUJA%3D%3D"}],"group":"cf-nel","max_age":604800}
server: cloudflare
strict-transport-security: max-age=31536000
vary: Accept-Encoding
x-hs-cache-config: BrowserCache-5s-EdgeCache-180s
x-hs-cache-control: s-maxage=10800, max-age=0
x-hs-cf-cache-status: MISS
x-hs-content-campaign-id: 0806c285-8485-468f-b7e9-a19cbf0af881
x-hs-content-id: 106512198193
x-hs-hub-id: 2355593
x-hs-prerendered: Sat, 25 Mar 2023 22:02:21 GMT

GET
H2 200 comment_listing_asset.js Show response
blog.visiblealpha.com/hs/hsstatic/AsyncSupport/static-1.122/js/ 8 KB
3 KB 45ms
43ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/hsstatic/AsyncSupport/static-1.122/js/comment_listing_asset.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

043cfebfa4ec302e0368eadbae54853a5b6caff633b3d1e02a32f2cd2f71e1fd

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 f47fcc9b2aa47ced36c40c318e6f006a.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: 4D3b_.jtdSCbU1XTktruWk73HT0wxWk7
age: 2268463
x-amz-cf-pop: DUS51-P2
x-amz-server-side-encryption: AES256
content-encoding: br
x-cache: Hit from cloudfront
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Fri, 17 Dec 2021 15:26:09 GMT
server: cloudflare
etag: W/"2455723721db341ff86a4f64384a9c0d"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=CEb%2BbHCxxec%2BoBh6dxq9%2BamzGMDOge7SMHaToz4XQ4lZWIYEtyJfTRenOpplJni4T%2FASdQY9Y5%2BMkggfepFJ8hKhHgDmFmsdreGBUU0Xj5cEBNiBQxMb3kNPseWCvl79DcthASQdjFkmnHzgLZ0%2F7%2BQbGw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
cache-control: public, max-age=31536000
cf-ray: 7ae0aa0e28dd997a-FRA
x-amz-cf-id: l4586TCY42m6dNyn7iZ01ghdwlg_u3vnMfBhReCaJuZCQh_oAgNcLg==
expires: Mon, 25 Mar 2024 16:10:32 GMT

GET
H2 200 project.js Show response
blog.visiblealpha.com/hs/hsstatic/keyboard-accessible-menu-flyouts/static-1.17/bundles/ 2 KB
982 B 49ms
48ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/hsstatic/keyboard-accessible-menu-flyouts/static-1.17/bundles/project.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

fb56af9f7623a55839dfb9cf019b05664a62e1b41671d925f3ed587c506443b5

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 7ef588f1ad9c3a185cdaf4119943040e.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: gEenO44eZUewxnIWfgj9q6LB.g9OszNv
age: 2268410
x-amz-cf-pop: DUS51-P2
x-amz-server-side-encryption: AES256
content-encoding: br
x-cache: Hit from cloudfront
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Wed, 19 Aug 2020 22:24:11 GMT
server: cloudflare
etag: W/"ef84f26c310485299d6b75777414eddb"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RaLGe2ocfR05HS4f8JrJo3zGU12xspy8CPa9jVcKqBlH8DhKiV8pXfmOfkWtcSrj3neOzPeJPxDpc4WKz5ND1jzt5T0p84EN9P1sHoAVdvFXMFqZtVRHghWw7lHOvL7wnWDYmLVlYK6r2ECOwj6lJRDH3Q%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
cache-control: public, max-age=31536000
cf-ray: 7ae0aa0e38e2997a-FRA
x-amz-cf-id: LNgj2ZIytuqwkMnVDvc_2UlrPogsB_9S_K5-bFYWj8ZYsrBK9EcLUw==
expires: Mon, 25 Mar 2024 16:10:32 GMT

GET
H2 200 index.js Show response
blog.visiblealpha.com/hs/hsstatic/HubspotToolsMenu/static-1.154/js/ 11 KB
5 KB 42ms
41ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/hsstatic/HubspotToolsMenu/static-1.154/js/index.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

49c050c7a4775b5b84a5ceabf44f33074c79c051306286a8be611e9794704894

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 11e35514d631a9a9566fd489de935c06.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: zqfoHVEO7SsMjSP1JrsnDQf9ix87l6qJ
age: 3889458
x-amz-cf-pop: FRA56-P2
x-amz-server-side-encryption: AES256
content-encoding: br
x-cache: Hit from cloudfront
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Thu, 09 Feb 2023 15:43:08 GMT
server: cloudflare
etag: W/"d57b3d84e0be8dd0aef0781d100c0d14"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=rUcBZ82SAFFv8cleyaR75Gcvm91Y405Ft60KFE68IqTssaFy2%2BtfEIjTFPrhkpeA113k1UacndjlSM%2BWeqBmCVspxQnUuoE0jODFuWf%2BEVkFC804vfZjme4PEEJVGwbJiDfbe4n%2B8Ab03qSIGMqAdKeTdg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
cache-control: public, max-age=31536000
cf-ray: 7ae0aa0e38e6997a-FRA
x-amz-cf-id: ch9PXkVWCvH2nOsOte7w4xPGtsY9EwL9b1YbIuksFbdyi3VU8AiTBw==
expires: Mon, 25 Mar 2024 16:10:32 GMT

GET
H2 200 project.js Show response
blog.visiblealpha.com/hs/hsstatic/cos-i18n/static-1.53/bundles/ 1 KB
1 KB 42ms
41ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/hsstatic/cos-i18n/static-1.53/bundles/project.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

8da927b6b1240ffca4323fbb2a12c8e5abb541040965c2bc5b7d09a2eb963b02

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 93b8205e2f07a7099af2e6fd126d9658.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: P9ES7sOpFzrLl1QoRwjEAy5outPo5_GO
age: 540127
x-amz-cf-pop: FRA56-P2
x-amz-server-side-encryption: AES256
content-encoding: br
x-cache: Hit from cloudfront
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Tue, 09 Nov 2021 16:12:42 GMT
server: cloudflare
etag: W/"61ca66de658cab9587e4636894680d5d"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=C%2FrjfJNU3NadUHzYct7jw1LOqaRtTTdn%2BHKcccBA%2BIKBzz4V1m%2B63i8lmVZLPNlt3YFggQa0HHqS7ecYwEsbzJRIptf5nsfUmkd5cBVpPLPME7bxTQLCMcaY8%2BVy3%2F7lQ0wqCXlFevTcO6l4hNdqd9DYtw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
cache-control: public, max-age=31536000
cf-ray: 7ae0aa0e38e7997a-FRA
x-amz-cf-id: vMxH2clCDRRjd7emHmifSLXhLc2TFOGFc0VsUqlcTSiVQmWY_1aUGQ==
expires: Mon, 25 Mar 2024 16:10:32 GMT

GET
H2 200 v2.js Show response
blog.visiblealpha.com/_hcms/forms/ 519 KB
169 KB 41ms
40ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/_hcms/forms/v2.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

0cf36478d6948fe47ca29577bfa6b8c7aff1794674cde4da0fea6c5c79a2416d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 e21fbbed60133ff896ee44224814dc5c.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: BcUKT19jvqha_mCJECQcCiOx8gVJnm0b
age: 184
x-amz-cf-pop: IAD12-P3
x-amz-server-side-encryption: AES256
content-security-policy-report-only: frame-ancestors 'self'; report-uri https://exceptions.hubspot.com/csp/report?resource=forms-embed/static-1.2916/bundles/project-v2.js&cfRay=7ae0a59400d7699f-IAD
x-cache: Hit from cloudfront
cache-tag: staticjsapp-forms-embed-v2-web-prod,staticjsapp-prod
content-encoding: br
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Thu, 23 Mar 2023 02:39:35 UTC
server: cloudflare
etag: W/"c3874180dd1cb2b9fa1505de5d7b5e30"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=85TukTGmnjHo1LptnKFTtGcoTlkcLRNNYhFDLUAvan6kLCg%2Fl09I52R60otMmyHOoEMjF7nhBhJZtz6dsfs5zR6cIeY82%2Bgu0cf4V0fgegHa6hK1sexx6OZCNdUQHrD4AWm6e%2BluAcqsBr7m%2B6vZ2KER%2BA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
x-hs-cache-status: HIT
cache-control: s-maxage=600, max-age=300
cf-ray: 7ae0aa0e38e8997a-FRA
x-amz-cf-id: qIYuQrnAj1lX0nJb5OnjaPDnEDLte9cA71CpGE6ibjEUc-bys0XCdw==
x-hs-target-asset: forms-embed/static-1.2916/bundles/project-v2.js

GET
H2 200 jquery-1.7.1.js Show response
blog.visiblealpha.com/hs/hsstatic/jquery-libs/static-1.1/jquery/ 92 KB
34 KB 42ms
40ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/hsstatic/jquery-libs/static-1.1/jquery/jquery-1.7.1.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

88171413fc76dda23ab32baa17b11e4fff89141c633ece737852445f1ba6c1bd

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 ddd7d19501f4b19d560bfedbdd9b13ce.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: null
age: 5214180
x-amz-cf-pop: DUS51-P2
content-encoding: br
x-cache: Hit from cloudfront
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Tue, 25 Nov 2014 17:03:30 GMT
server: cloudflare
etag: W/"ddb84c1587287b2df08966081ef063bf"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=7F6PXnfrx4AQeuAMVhXyyo08y3ZH%2FNZFQhO2OwR1T84SEcBG6%2FDouWvajYcvtbOoGLRFemhSSlzAz%2BUg%2B%2BA84a96T5YpQnnSaP3O08tvvAxGk6E3mvMsJjoBE%2FFBxMkq1JegKF9%2BmOrZE2B611Jq8MoE8w%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
cache-control: public, max-age=31536000
cf-ray: 7ae0aa0e38eb997a-FRA
x-amz-cf-id: fm5oEyshHguW5eyTWJujGExVMJHQq6j4KXVELLj8_f20U-gCmo27Iw==
expires: Mon, 25 Mar 2024 16:10:32 GMT

GET
H2 200 module_56804756318_Related_Post_for_Single_Post.min.css
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/module_assets/56804756318/1661956282447/ 1 KB
1 KB 313ms
311ms Stylesheet
text/css 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/module_assets/56804756318/1661956282447/module_56804756318_Related_Post_for_Single_Post.min.css

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

efa6542047cc0f4a35d3579a36fa938ea785687575727d268686dd653395b3ce

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 0920aeb1eced22df07c9ece1cab0a554.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: tZs1VpuQt97mp3Lh9i6JOHR9BchrlHqm
x-amz-cf-pop: IAD89-P1
x-amz-request-id: NH19XKV3H67QR84J
x-amz-server-side-encryption: AES256
x-hs-alternate-content-type: text/plain
x-cache: RefreshHit from cloudfront
x-amz-storage-class: INTELLIGENT_TIERING
content-encoding: br
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-id-2: czDQthEIRmkQ30GMvaOT+FU4ybofRJ4q+SE3ZAKyUc0N4qhPR37p/JlCJR0VuyKKO6ARfAZHiUd26ZgxrkibZQ==
last-modified: Wed, 31 Aug 2022 14:31:23 GMT
server: cloudflare
etag: W/"fe4838f86996387d69d3f8d2269b3b34"
vary: origin, Accept-Encoding
x-amz-meta-created-unix-time-millis: 1661956282447
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=SGMi7NyP2cBPOlHN%2BwNtUf%2FwVJ1BCfNUm1XsI6EvvTFFlmNiJjU28SYWiIHwgY6pff2Q%2B9omrnmaT25Z15OTNhpx5xAeF%2Br9dnFvkyZZoM8M88SoK7%2B9HDJ8Gve4qHUlVBxv9yntlNqryvMAunc9ZiW2Zg%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
cf-ray: 7ae0aa0e38ee997a-FRA
x-amz-cf-id: mGXxKWe9RGXp1EWC3gwL1pMaox-6r0N6HgJpMbQ3umbVGadlEMCd4w==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18

GET
H2 200 comments_listing_asset.css
blog.visiblealpha.com/hs/hsstatic/AsyncSupport/static-1.122/sass/ 1 KB
1014 B 48ms
46ms Stylesheet
text/css 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/hsstatic/AsyncSupport/static-1.122/sass/comments_listing_asset.css

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

ed92c951c39983af4f5fac78a5bab4c390b3faf7c46e2a35256ee38f5443ffa2

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 5721f7035c3fc934bd3f96dbb04ba1e4.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: LQgaE1SSZjkxZtePb5jE9vLc6kDw7LTx
age: 5259907
x-amz-cf-pop: FRA50-C1
x-amz-server-side-encryption: AES256
content-encoding: br
x-cache: Miss from cloudfront
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Fri, 17 Dec 2021 15:26:10 GMT
server: cloudflare
etag: W/"6b1d31d121f4c84e5ee3b7d7446495d8"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=EeFjItCc4yjUTsirq6DkwSaz3XlH%2BHP32z%2FMdU0iBwGCRFVaNEQHZAzuoxTR3QafEQkCYdc0Tks70ynIkusLhPSTa43Hm8lHGmXtVKOIo8uNdK25D1Nnc%2Bx6vVokNiEpU%2B%2FpLpKoLBjNmLT3DysKQZaDtA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: public, max-age=31536000
cf-ray: 7ae0aa0e38f0997a-FRA
x-amz-cf-id: fJXTM8_wGdLcvZA0pcUe1GoGeXAikcdvRMnesJjyhs53QY25pZR11A==
expires: Mon, 25 Mar 2024 16:10:32 GMT

GET
H2 200 in.js Show response
platform.linkedin.com/ 509 KB
160 KB 128ms
25ms Script
text/javascript 2a02:26f0:480:e::210:f113
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://platform.linkedin.com/in.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:480:e::210:f113 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

Software

Play /

Resource Hash

0498b01282b4876d7d7f5502d62ea3764ec0039db75f1d5acd33acae2c63a040

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
x-cdn-client-ip-version: IPV6
server: Play
x-li-pop: prod-ltx1-x
x-cdn: AKAM
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
x-li-fabric: prod-ltx1
cache-control: public, max-age=3600
x-li-proto: http/1.1
content-length: 163382
x-li-uuid: AAX3z7icLyTILOs82RYTxw==
expires: Sun, 26 Mar 2023 17:00:11 GMT

GET
H2 200 layout.min.css
cdn2.hubspot.net/hub/7052064/hub_generated/template_assets/1679679316537/hubspot/hubspot_default/shared/responsive/ 4 KB
2 KB 85ms
56ms Stylesheet
text/css 2606:4700::6811:f4cc
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn2.hubspot.net/hub/7052064/hub_generated/template_assets/1679679316537/hubspot/hubspot_default/shared/responsive/layout.min.css
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6811:f4cc , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 257855f4e23a1e3d382077b15bfc30971c9c261fc23512c88abfdcda05f28bc4

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age: 167615
x-amz-cf-pop: IAD89-P1
x-amz-server-side-encryption: AES256
x-hs-alternate-content-type: text/plain
x-amz-storage-class: INTELLIGENT_TIERING
x-amz-replication-status: COMPLETED
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 15
last-modified: Fri, 24 Mar 2023 17:35:18 GMT
server: cloudflare
etag: W/"94daf62e7e6df83595c6251fb0c7c055"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: text/css
access-control-allow-origin: *
x-amz-meta-created-unix-time-millis: 1679679317490
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=SwSHdHm5wP4S%2FmNspm2JWXOweJM975GBD8DCmlNy3Qi2Q8Ia4P3ESuetWXnyDapuvjC6hACgAlv8FlTJdDxbYhwBMQuVggAqQ8upc5DIHJGBQkA4ftqT2kloyIaw8KbKvVXyZiXVRvdaVPSPYUE%3D"}],"group":"cf-nel","max_age":604800}
cf-ray: 7ae0aa0e5b4e9214-FRA
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 15

GET
H2 200 nickel_2017.min.css
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5678766005/1679335755348/Nickel_Blog_Theme_2018/Code/css/ 280 KB
31 KB 300ms
298ms Stylesheet
text/css 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5678766005/1679335755348/Nickel_Blog_Theme_2018/Code/css/nickel_2017.min.css

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

ccdae76fbec88cdeba683ef746192d4329c5d2ae905cf10ad66c67ed14f28b55

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 ea3bfccd683c652cb849f6ec1b5606a4.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: GnTxYycmS8GwgqTy0lOOHFiqB2RXK7pg
x-amz-cf-pop: IAD89-P1
x-amz-request-id: H451FAR9Y6764JRJ
x-amz-server-side-encryption: AES256
x-hs-alternate-content-type: text/plain
x-cache: RefreshHit from cloudfront
x-amz-storage-class: INTELLIGENT_TIERING
content-encoding: br
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-id-2: U+foHLCRozbybOORKH1zeNvU9H8zpIdTqdGfhjiKn2NvPOR4dtjnKuOfAzD1FtHAC/z+xF4On0Q=
last-modified: Mon, 20 Mar 2023 18:09:18 GMT
server: cloudflare
etag: W/"8b163ce61c85debebc19491bded2b8bb"
vary: origin, Accept-Encoding
x-amz-meta-created-unix-time-millis: 1679335757274
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=BRzPx2Sak8%2FXwtTPk2%2BXbjgc1Uv3pgB29bsDiwPRpfvH8dd%2B%2Bxej77TrPNv2gakCR3lpBid6SkteoqOcHAo%2FgLv%2Fh0qRBaQs5s1DdBR%2FaW7fPEPWgzfbY3EHx81a1CrVXkwpQAddZQQU8nx3vbHjTrvhGQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
cf-ray: 7ae0aa0e38f3997a-FRA
x-amz-cf-id: A41gbN5Z1mG2x9FUVxLqYCxCtPyxfbuntKfyzzB3mk_PVnFljsvicA==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18

GET
H2 200 Visible_Alpha_April2018-style.min.css
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521177/1661441551520/Visible_Alpha_April2018_Theme/Code/css/ 41 KB
9 KB 286ms
285ms Stylesheet
text/css 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521177/1661441551520/Visible_Alpha_April2018_Theme/Code/css/Visible_Alpha_April2018-style.min.css

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

801c3aa6abe4e09779b0415eed67fada260aa8d5507049e672eebc0c98db0488

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 5630c5d6ce3870273aaf2ed5fe6c2f14.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: xcOPIo3t6VgHr2tg4notnE1GT6g_cKg5
x-amz-cf-pop: IAD89-P1
x-amz-request-id: ZB4P117M0XC953FD
x-amz-server-side-encryption: AES256
x-hs-alternate-content-type: text/plain
x-cache: RefreshHit from cloudfront
x-amz-storage-class: INTELLIGENT_TIERING
content-encoding: br
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-id-2: l8/JwIJh+lBE+yvZIsD86C3WIfHxGrTkIv1Jx7wwGG6IeYGWV5145m4lmMT62ZbdttRzejfUcU8=
last-modified: Thu, 25 Aug 2022 15:32:33 GMT
server: cloudflare
etag: W/"057b398185c05c6b55b3e66d3fe4021e"
vary: origin, Accept-Encoding
x-amz-meta-created-unix-time-millis: 1661441552561
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=2n2bUQdfR6lpaHSziYC1G2GVUqGfIsrItZyJprL3ulKlkoB0XvE1DWxwrgt3q9nP91FQn%2FZ75qDyIStGzc%2BBdUWcBRNoAlxgrjUoxf04%2Bs2LvYFIBZYNWFsGezYaujA2Kv%2FyI0fwgwawV%2FLMR0lV7LHPrw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
cf-ray: 7ae0aa0e38f4997a-FRA
x-amz-cf-id: HHO37366CdgCFGdNGNNGYky9goyhNRNut-dpHPxKI44LV8IIYKJVIw==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18

GET
H2 200 nickel-custom.min.css
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/6297554256/1666101947735/Nickel_Blog_Theme_2018/Code/css/ 2 KB
2 KB 258ms
257ms Stylesheet
text/css 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/6297554256/1666101947735/Nickel_Blog_Theme_2018/Code/css/nickel-custom.min.css

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

90cab5a997bbb75bc92e79afe3117adf1052c6f83d31f56fc2a4ed1dbe10063f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 4ee1745ee3cece0fab563f5a32ba165a.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: Y6be0_fomQg27tvZKKn6vSQRrbtM6kY1
x-amz-cf-pop: IAD89-P1
x-amz-request-id: G7SBFA0HDHY1EX80
x-amz-server-side-encryption: AES256
x-hs-alternate-content-type: text/plain
x-cache: RefreshHit from cloudfront
x-amz-storage-class: INTELLIGENT_TIERING
content-encoding: br
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-id-2: FI3AsPyj4g11z7oYkTXJyG8h5sJTU8tZ53HsEwp5pnAnulq4HCAQgDCWv1Rr9yqis+rYEkEf7E8=
last-modified: Tue, 18 Oct 2022 14:05:49 GMT
server: cloudflare
etag: W/"86b3501b89e3159cf4b0c212ca93a9c2"
vary: origin, Accept-Encoding
x-amz-meta-created-unix-time-millis: 1666101948989
content-type: text/css
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ILJPKYXgseRvRFSvoqOssDgQ0RnAXgztJoSdAuV9zOR8IXqoYNBH27GUV04sxG4GBLcUEVmjHWAekFFRRHc4QAKx1X9GNy9YQoaAvbzO%2FSQgknhi5E1ZnQ7FC5KjXw4grzrLqDmsanLr1Qd2IvTaatgiaw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
cf-ray: 7ae0aa0e38f8997a-FRA
x-amz-cf-id: Z1HKj9SqnNy_CegnHib4YXoYKabAA-PL9rnwryJ1C1HOr_kJ1TEe6w==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18

GET
H2 200 nickel-fixes.min.css
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/6834941253/1569931754722/Nickel_Blog_Theme_2018/Code/css/ 2 KB
1 KB 264ms
263ms Stylesheet
text/css 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/6834941253/1569931754722/Nickel_Blog_Theme_2018/Code/css/nickel-fixes.min.css

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

005d2d635a2394b196d42260d69939edb5eaeb388856a6423a47a871ad14f3c1

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 5e1f849553b1d58615d0d8f7c044078e.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: 3uq2HC6eOEfnV2jcQPCQqMbdl27Pr.OF
x-amz-cf-pop: IAD89-P1
x-amz-request-id: G7S0TQWZ4HWSJBF6
content-encoding: br
x-cache: RefreshHit from cloudfront
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-id-2: kx5t1rQXS7sH77289aDK1WvyyCz1eLJxKezDNo+kFyz3JfxXN3R0FzQzuXvhtKTsDxrbXcc1gv4=
last-modified: Tue, 01 Oct 2019 12:09:15 GMT
server: cloudflare
etag: W/"b575c0c943c2e67f7198833a127987c4"
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=n%2FzdLoO37TXbbtDpjkY8J6Y8TG%2Fmddr23h6PJldSAzsIZOezPYvnigOm79p4hRZhjCZJpKIW3Lfj2tSBZ7Fnuu4igvmqj5eq2nx4fjCtf8We1umrGyj1Zf0u6uqgdc76v41OYo2QQiynLh3XX83zrMEAig%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
cf-ray: 7ae0aa0e38fa997a-FRA
x-amz-cf-id: 1y6NV58COfB5zODZ4qqLq68TMVHigQuK9HrIzYcFxt3e-EOcdUH9bg==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18

GET
H3 200 visible-alpha-logo1.png
blog.visiblealpha.com/hs-fs/hubfs/ 17 KB
18 KB 1005ms
1001ms Image
image/png 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hs-fs/hubfs/visible-alpha-logo1.png?width=500&name=visible-alpha-logo1.png

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

a5a30d9e861ec82257daa657a8bf45446993f2ddd6a0f16021c1e6f58dda773d

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
via: 1.1 3e6bcbe331beee2f38e13259af01af8e.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'
cache-tag: F-26845128891,P-2355593,FLS-ALL
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 17825
cf-resized: internal=ok/m q=0 n=925+0 c=1+1 v=2023.3.5 l=17825
last-modified: Tue, 10 Mar 2020 00:39:07 GMT
cf-bgj: imgq:0,h2pri
server: cloudflare
etag: "cfssi996A29FeCcBgZhBQtnxL8iQ6hd_SV2P5CaOb0DQ:cbeeaa6efc8b530a5d3fe2228183631a"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=bm28acguAttQUPqOXQRmCu9KyAZTTiHbiybWWnrJE%2FfX59QEzKfKYpJKijq0L65t4uIBR4QtOt9GcTrr4MzHoPGPdQOOC5vMWivhFQxe%2FefkIL4v7oUPKu7nIknpn1n7%2BWf1Q3Gn%2B%2Ber2YPrpMgPqy3%2FUw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/png
access-control-allow-origin: *
cache-control: max-age=1209600, s-maxage=1814400, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 7ae0aa103e2c9a18-FRA

GET
H3 200 shutterstock_1853126911%20%281%29.jpg
blog.visiblealpha.com/hubfs/ 938 KB
939 KB 1012ms
1008ms Image
image/jpeg 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hubfs/shutterstock_1853126911%20%281%29.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

bb99c511e1d379beac06b4b58a1ded20068ba5c5ce4eb5c5de851904dece180d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-amz-meta-cache-tag: F-106520495186,P-2355593,FLS-ALL
x-amz-request-id: 4SHQDBH896SQZ5QG
x-amz-server-side-encryption: AES256
edge-cache-tag: F-106520495186,P-2355593,FLS-ALL
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
etag: "9aa61575c1ebb05780aa6bdfc4e36d93"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: image/jpeg
access-control-allow-origin: *
x-amz-meta-created-unix-time-millis: 1678831354324
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
x-robots-tag: all
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18
date: Sun, 26 Mar 2023 16:10:33 GMT
strict-transport-security: max-age=31536000
via: 1.1 5d27236a5f6fb9836424f23bb92b0cd0.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: .1O1BVpe7F2At4S_crRz0Hym43JWuAaW
x-amz-cf-pop: MXP64-P1
x-hs-alternate-content-type: text/plain
x-cache: Miss from cloudfront
cache-tag: F-106520495186,P-2355593,FLS-ALL
x-amz-meta-index-tag: all
x-amz-storage-class: INTELLIGENT_TIERING
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 960203
x-amz-id-2: LLc3pXi6sMjiYtZrO9MSTevFMM7JgexoNKhQiHDfvOVjikqsCbAH+X9SqG5n11bvbX5LE6p9cuU=
last-modified: Tue, 14 Mar 2023 22:02:35 GMT
server: cloudflare
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=%2BExaRXlbEnQmfdMi06cvK8tJuMR7P6cc%2BbFg0b8Jn68KfRtA3JH3%2Btqqz7A5vbNs09zWo3hBarKcSbRsEz5nHT5IrbO2rVmilTeBaa7EILh7kLPIf5GuA20Y%2FJ%2BnE5EjUbrHxFGtkXRVcdY2Y%2B7Fg%2BuH3g%3D%3D"}],"group":"cf-nel","max_age":604800}
accept-ranges: bytes
cf-ray: 7ae0aa103e2d9a18-FRA
x-amz-cf-id: x1pIxkGwUCuHczeaFbjFatg9nnFR1cvyMghNlOO6xJxBJTP-5TlAnA==

GET
H3 200 Jasuja_Rahul_7198-1800x1800.jpg
blog.visiblealpha.com/hs-fs/hubfs/ 3 KB
4 KB 1262ms
1258ms Image
image/jpeg 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hs-fs/hubfs/Jasuja_Rahul_7198-1800x1800.jpg?width=150&name=Jasuja_Rahul_7198-1800x1800.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

7ff5c62870739fded82347b99e712ef4f887a54526a1a208297a1ebea0a4cb48

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
via: 1.1 66a3254753daef98131e391b49752390.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'
cache-tag: F-103686964354,P-2355593,FLS-ALL
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 3090
cf-resized: internal=ok/m q=0 n=1137+0 c=33+20 v=2023.3.5 l=3090
last-modified: Wed, 22 Feb 2023 17:50:17 GMT
cf-bgj: imgq:85,h2pri
server: cloudflare
etag: "cf4frdSO7s19ANZPPyYXn9BxqRt404ZI_GI4hmVMV0DQ:d7fd68ab493a30eb16772dc0ee46b510"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=0Lih2xqQV18Ek9luACvdU%2BQIHOD9zaFQZDZ2mRM%2F4zlNMabJY80Mj3MhpMo8XYkBOlcxTCmTcgMjAUYuXF4yQhw%2FXM2kbxS0Ut1%2BX2r4JJqBUMCp3jSwRIisO7kYBbTy9TE7zcDF9mq%2BtUCNhClYe1OMSw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
access-control-allow-origin: *
cache-control: max-age=1209600, s-maxage=1814400, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 7ae0aa103e2e9a18-FRA

GET
H2 200 shutterstock_1009681927.jpg
2355593.fs1.hubspotusercontent-na1.net/hub/2355593/hubfs/ 16 KB
17 KB 534ms
501ms Image
image/jpeg 2606:4700:4400::ac40:9ad8
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://2355593.fs1.hubspotusercontent-na1.net/hub/2355593/hubfs/shutterstock_1009681927.jpg?width=375&name=shutterstock_1009681927.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:4400::ac40:9ad8 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

104e92d58b67570a9ffd51cdba36465fa42dc14f6d03f975ced506f7170b3018

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
via: 1.1 7afe17509cf46af31fd4ba3c3d932fa6.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'
cache-tag: F-107226972333,P-2355593,FLS-ALL
content-length: 16877
cf-resized: internal=ram/m q=0 n=435+0 c=2+24 v=2023.3.4 l=16877
last-modified: Mon, 20 Mar 2023 16:37:43 GMT
cf-bgj: imgq:85,h2pri
server: cloudflare
etag: "cfkwpwefyjvQY21o-kmjYsia4cR3MZG7JLscW6wyHODQ:f2f5d778323231b58e7d6db7bcd046d0"
vary: Accept, Accept-Encoding
content-type: image/jpeg
access-control-allow-origin: *
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 7ae0aa106c8d39e5-FRA

GET
H2 200 Ted%20Lasso%20v%20Machester%20United.jpg
2355593.fs1.hubspotusercontent-na1.net/hub/2355593/hubfs/ 21 KB
22 KB 247ms
214ms Image
image/jpeg 2606:4700:4400::ac40:9ad8
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://2355593.fs1.hubspotusercontent-na1.net/hub/2355593/hubfs/Ted%20Lasso%20v%20Machester%20United.jpg?width=375&name=Ted%20Lasso%20v%20Machester%20United.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:4400::ac40:9ad8 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3e364085b43ae0b6025e875b45a860a37e242c51058d40e2ea065fd5e4e9701c

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
via: 1.1 4a050b98a443ca2d3af477f9b4dc39ae.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'
cache-tag: F-106791488427,P-2355593,FLS-ALL
content-length: 21492
cf-resized: internal=ok/m q=0 n=207+0 c=2+32 v=2023.3.3 l=21492
last-modified: Thu, 16 Mar 2023 17:30:15 GMT
cf-bgj: imgq:85,h2pri
server: cloudflare
etag: "cftXSqGJE3r3hfs5UMOiSsBBKbR3MZG7JLscW6wyHODQ:4f1f90b5cd34f7be9a1e5b8cc72a1490"
vary: Accept, Accept-Encoding
content-type: image/jpeg
access-control-allow-origin: *
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 7ae0aa106c8f39e5-FRA

GET
H2 200 Model%203%20and%20Model%20Y%20to%20Continue%20Dominating%20Tesla%20Sales%3B%20Carvana%20Sales%20Estimates%20Crash.jpg
2355593.fs1.hubspotusercontent-na1.net/hub/2355593/hubfs/ 8 KB
9 KB 248ms
215ms Image
image/jpeg 2606:4700:4400::ac40:9ad8
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://2355593.fs1.hubspotusercontent-na1.net/hub/2355593/hubfs/Model%203%20and%20Model%20Y%20to%20Continue%20Dominating%20Tesla%20Sales%3B%20Carvana%20Sales%20Estimates%20Crash.jpg?width=375&name=Model%203%20and%20Model%20Y%20to%20Continue%20Dominating%20Tesla%20Sales%3B%20Carvana%20Sales%20Estimates%20Crash.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:4400::ac40:9ad8 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9affacff231762b9abea384666817a39d18ecc1ddf15c0bf3c295407ad748992

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
via: 1.1 8c1cde7cef0a6f5dc839234d2bb2bca4.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'
cache-tag: F-105015612536,P-2355593,FLS-ALL
content-length: 8482
cf-resized: internal=ram/h q=0 n=147+0 c=2+16 v=2023.3.4 l=8482
last-modified: Fri, 03 Mar 2023 21:12:48 GMT
cf-bgj: imgq:85,h2pri
server: cloudflare
etag: "cfLOrrENQAXfFRMYcrhJPlosqoR3MZG7JLscW6wyHODQ:aa8aa4cfffe591bcb15ace83038f6036"
vary: Accept, Accept-Encoding
content-type: image/jpeg
access-control-allow-origin: *
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 7ae0aa106c9039e5-FRA

GET
H2 200 8694811b-cee5-48c6-878f-b29131776884.png
no-cache.hubspot.com/cta/default/2355593/ 265 KB
266 KB 215ms
188ms Image
image/png 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://no-cache.hubspot.com/cta/default/2355593/8694811b-cee5-48c6-878f-b29131776884.png

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

0ebd2ded8c705a2bfaf2a0b7fbdce1608f10256cb30358c8ebaac17833aa6f7a

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
x-amz-version-id: null
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-amz-request-id: 4SHV3MQB336R7XKP
x-amz-server-side-encryption: AES256
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 271462
x-amz-id-2: xPGTD3ouEHuFbf/XaW0mI9+ANfnJGj0Nryf/MGDR0uJklMUpkd/Kh7tvX1rBue/es3ilO/fKPA5dsKl3LVRe8PFPkpTKgHlEKDu5JroiKpQ=
last-modified: Fri, 18 Sep 2020 16:32:24 GMT
server: cloudflare
etag: "2d8fcc01b56f82b641f8dea4a39cbfb4"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=z1EdtOHZY9N6SL3eSvXCQAzJvayOC1CW3e7D694PZQLKusixypTwMZMPVgmzNF08Lbgx9DHPiNUYs5RZp2JNO6nUIBP5veaRupAzMXuSu7mOWR6TuEPwK%2Ff%2Bg%2FLO7aunSDq1G4eScJxGbFXdXEf101RA"}],"group":"cf-nel","max_age":604800}
content-type: image/png
cache-control: no-cache, no-store
accept-ranges: bytes
cf-ray: 7ae0aa105b37bbfd-FRA

GET
H3 200 current.js Show response
blog.visiblealpha.com/hs/cta/cta/ 16 KB
7 KB 56ms
56ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/cta/cta/current.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

c325a3a446a33b8dfb329feec9df9c003de983a5c64bc3d27696c646e8d963c6

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 4715507645a6516d2df35cd342cb5be0.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: O_dI.J5OwqlyrSQnZwBt_38jV6NFMeLX
age: 296
x-amz-cf-pop: IAD12-P3
x-amz-server-side-encryption: AES256
content-security-policy-report-only: frame-ancestors 'self'; report-uri https://exceptions.hubspot.com/csp/report?resource=cta-embed-js/static-1.140/bundles/current.js&cfRay=7ae0a2d74752691f-IAD
x-cache: Hit from cloudfront
cache-tag: staticjsapp-CtaEmbed-cloudflare-web-prod,staticjsapp-prod
content-encoding: br
x-amz-replication-status: COMPLETED
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Tue, 28 Feb 2023 05:00:29 UTC
server: cloudflare
etag: W/"2a447451325b0ef178f8f05aa802c484"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=reYxYydayss3W%2FLcBuGdYVfPAYk2rMu%2FUyoHQpuk%2FWS96KVv69BwWfDcQ6q723ykKDNV3G3XiBc7ANOR3TakFuvZC5pUDRFizfjf3j8olmekL%2BhgcaFNuLITSC%2BKGiD0Ifef%2BXA%2FsDQQSPaKl3F%2FGcQ%2Btw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
x-hs-cache-status: HIT
cache-control: max-age=600
cf-ray: 7ae0aa101e059a18-FRA
x-amz-cf-id: ENyXHm9GJJ07StvpvOnF6vbptLArKd5_Yo1UnpjWD6mmzUka6FwmUw==
x-hs-target-asset: cta-embed-js/static-1.140/bundles/current.js

GET
H2 200 jquery.slicknav.min.js Show response
cdnjs.cloudflare.com/ajax/libs/SlickNav/1.0.10/ 8 KB
3 KB 33ms
15ms Script
application/javascript 2606:4700::6811:180e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdnjs.cloudflare.com/ajax/libs/SlickNav/1.0.10/jquery.slicknav.min.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

87f4f0b8142a441884c70d2c2bf1ddc33248eee60506b27611ba3b827f401b3e

Security Headers

Name	Value
Strict-Transport-Security	max-age=15780000
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=15780000
age: 300509
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 2360
last-modified: Mon, 04 May 2020 16:04:02 GMT
server: cloudflare
cf-cdnjs-via: cfworker/kv
etag: "5eb03cf2-212c"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=GflKOFiCiGmDjgl%2F%2FaMZi8KldlLlgek1AteXTCzjHyRppuIz%2FVABDbfmCHdy5xR3bqbjzn7nVxJia9%2BbqzDFrtRLakn2z6dIRxMjCrvtiwQYtGtBSWVtHh3EbBzUv4ApIe8QAtTgufIPvP4y%2B%2Bi1k%2Ffq"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=30672000
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 7ae0aa1048be929b-FRA
expires: Fri, 15 Mar 2024 16:10:32 GMT

GET
H2 200 slick.min.js Show response
cdn.jsdelivr.net/jquery.slick/1.6.0/ 41 KB
11 KB 36ms
16ms Script
application/javascript 2606:4700::6810:5714
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.jsdelivr.net/jquery.slick/1.6.0/slick.min.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:5714 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e02af7df9a190d88380e2dcec2050ecaa493ae2d23526dbeec67f6907df3a752

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age: 2792215
content-encoding: br
x-cache: HIT, HIT
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-served-by: cache-fra-eddf8230080-FRA, cache-yyz4543-YYZ
server: cloudflare
etag: W/"a3e1-6fy8xPpwy6CTuB2YKht4UJQUzvc"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ZE92IZ3onDmIQKiEm1LONbCIo8fnHhsgLzSkCbrks4Ars1nslWrXboq3Uy5uvfSfSueyV8wgzUAAI6yx%2F7%2B78hlb9BsUunokEfZVa6GncfhazMOtSz93YFeBC%2BAhDVtoQ1%2FPcFOAopXm7upzFQQ%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: public, max-age=31536000, s-maxage=31536000, immutable
timing-allow-origin: *
cf-ray: 7ae0aa104e213602-FRA

GET
H2 200 wow.min.js Show response
cdnjs.cloudflare.com/ajax/libs/wow/1.1.2/ 8 KB
3 KB 33ms
17ms Script
application/javascript 2606:4700::6811:180e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdnjs.cloudflare.com/ajax/libs/wow/1.1.2/wow.min.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

cfa1739ee346d63a3d3cfdff8c18cbe8fdedbcb32d4b0895028c193ce828e7a5

Security Headers

Name	Value
Strict-Transport-Security	max-age=15780000
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=15780000
age: 4381869
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 2346
last-modified: Mon, 04 May 2020 16:17:55 GMT
server: cloudflare
cf-cdnjs-via: cfworker/kv
etag: "5eb04033-1ff6"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=gbsoKAiruPt4pR%2BRPZVGuD%2FhCqB4g4dVACN1kuyTmo1GtUgejTnZN9mGgIsTxK2Di5KsywxCfZDbFsjPAxP6mxjNvJejfpLnmnkQZen%2BS%2BOd3mNFa3tR13TwyYaiF%2Favg9BbuOGa%2Ftv%2BkwlIMhpGWJRP"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=30672000
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 7ae0aa1048bf929b-FRA
expires: Fri, 15 Mar 2024 16:10:32 GMT

GET
H2

200

imagesloaded.pkgd.min.js Show response
unpkg.com/imagesloaded@4.1.4/
Redirect Chain

https://unpkg.com/imagesloaded@4/imagesloaded.pkgd.min.js
https://unpkg.com/imagesloaded@4.1.4/imagesloaded.pkgd.min.js

5 KB
2 KB

18ms
18ms

Script
application/javascript

2606:4700::6810:7daf
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://unpkg.com/imagesloaded@4.1.4/imagesloaded.pkgd.min.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Server

2606:4700::6810:7daf , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

96abf166b3cbb5f7df525d86fdeeeccea4af3c120b19bc26b0613530a94e8b44

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
via: 1.1 fly.io
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains; preload
age: 539869
last-modified: Tue, 02 Jan 2018 16:53:35 GMT
fly-request-id: 01GVZ83HD0AB6RCNTYFST3V8SV-fra
server: cloudflare
etag: W/"15da-bT4RF04iZo5p3yNuXEVCFo98v+w"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=31536000
cf-ray: 7ae0aa10898992c9-FRA

Redirect headers

date: Sun, 26 Mar 2023 16:10:32 GMT
via: 1.1 fly.io
x-content-type-options: nosniff
cf-cache-status: HIT
fly-request-id: 01GWFAR7XE6GH29A05NP7NQCGB-fra
server: cloudflare
strict-transport-security: max-age=31536000; includeSubDomains; preload
age: 223
vary: Accept, Accept-Encoding
content-type: text/plain; charset=utf-8
access-control-allow-origin: *
location: /imagesloaded@4.1.4/imagesloaded.pkgd.min.js
cache-control: public, s-maxage=600, max-age=60
cf-ray: 7ae0aa10593092c9-FRA

GET
H2

200

isotope.pkgd.min.js Show response
unpkg.com/isotope-layout@3.0.6/dist/
Redirect Chain

https://unpkg.com/isotope-layout@3.0/dist/isotope.pkgd.min.js
https://unpkg.com/isotope-layout@3.0.6/dist/isotope.pkgd.min.js

35 KB
10 KB

22ms
21ms

Script
application/javascript

2606:4700::6810:7daf
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://unpkg.com/isotope-layout@3.0.6/dist/isotope.pkgd.min.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Server

2606:4700::6810:7daf , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

081ae9baaacc857c1c2cb51de6dbd0e1eb811c2761ef01a50df373f2f6eefe22

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
via: 1.1 fly.io
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains; preload
age: 5213752
last-modified: Sat, 26 Oct 1985 08:15:00 GMT
fly-request-id: 01FT83NHCWF1VYDKRC4E2TD43W
server: cloudflare
etag: W/"8a75-xOWZTyTujI0s8tZgLwtWuQlqLpg"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=31536000
cf-ray: 7ae0aa113a8c92c9-FRA

Redirect headers

date: Sun, 26 Mar 2023 16:10:32 GMT
via: 1.1 fly.io
x-content-type-options: nosniff
cf-cache-status: EXPIRED
fly-request-id: 01GWFAZ1J2V9395M5S5JWGJC95-fra
server: cloudflare
strict-transport-security: max-age=31536000; includeSubDomains; preload
vary: Accept, Accept-Encoding
content-type: text/plain; charset=utf-8
access-control-allow-origin: *
location: /isotope-layout@3.0.6/dist/isotope.pkgd.min.js
cache-control: public, s-maxage=600, max-age=60
cf-ray: 7ae0aa10593392c9-FRA

GET
H2 200 jquery.magnific-popup.min.js Show response
cdnjs.cloudflare.com/ajax/libs/magnific-popup.js/1.1.0/ 20 KB
7 KB 30ms
14ms Script
application/javascript 2606:4700::6811:180e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdnjs.cloudflare.com/ajax/libs/magnific-popup.js/1.1.0/jquery.magnific-popup.min.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:180e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3fddc6d28aba3c13d64cfd4847c333ff48c71d4a5a58bd1a0494ca6ae8ac1bb4

Security Headers

Name	Value
Strict-Transport-Security	max-age=15780000
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=15780000
age: 4414727
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 6546
last-modified: Mon, 04 May 2020 16:12:04 GMT
server: cloudflare
cf-cdnjs-via: cfworker/kv
etag: "5eb03ed4-4ef8"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Al%2BHxdqf1WAiY3mCBG88idvOsqqd66yj4bCGYL8cLLPgCj2IA5bxNwS87%2BBGuA0dvpfj9EOVl6x2M%2B%2BpeEggxVLfmmi0L3jfRX2Ro4MyzX%2BT95qS00WMa8m%2FzObM1Vpdixea%2BoLOzkZXwaEyuKCmCyOV"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=30672000
accept-ranges: bytes
timing-allow-origin: *
cf-ray: 7ae0aa1048c2929b-FRA
expires: Fri, 15 Mar 2024 16:10:32 GMT

GET
H3 200 facebook.jpg
blog.visiblealpha.com/hubfs/Visible_Alpha_April2018/Images/ 438 B
2 KB 46ms
43ms Image
image/webp 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hubfs/Visible_Alpha_April2018/Images/facebook.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

194b7fbf9bca91b1a9cc987c4832b96699475bb86ae535ae586b0d3091f2e6be

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-amz-meta-cache-tag: F-5688830076,FD-5688829971,P9snR,FLS
age: 18583
x-amz-request-id: XHMYQANGNWHEZF2E
edge-cache-tag: F-5688830076,FD-5688829971,P9snR,FLS
x-hs-https-only: worker
content-disposition: inline; filename="facebook.webp"
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
cf-bgj: imgq:85,h2pri
etag: "b3030b31061bf6c0541050d134631652"
vary: Accept, Accept-Encoding
access-control-allow-methods: GET
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18
date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 6be461c5a9399007c1540eee90371674.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: uVcoA2T7doEvPr6NK4QPBLTLEDoTy8lM
x-amz-cf-pop: FRA56-P7
cf-polished: qual=85, origFmt=jpeg, origSize=823
x-cache: RefreshHit from cloudfront
cache-tag: F-5688830076,FD-5688829971,P9snR,FLS
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 438
x-amz-id-2: IoriVHlUNh8C11p8bf+L2DP133Wj5hCLhjuLhuLlf0fqtj4p5pvbNE3c8nztG5LW67MxWnJrrmc=
last-modified: Mon, 09 Apr 2018 10:59:59 GMT
server: cloudflare
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=M4MJO0BGAqnSZYMpj84bXf10F8BwSZI3%2FbalgqdcoxhxA%2FmnCNKEoJErIJewpOvwN360IRyw6vgCvFP2P2v56scMyQZQImp5xALDI6VMxHcMXdsoYUEdZBphYowYseuwl3PP%2B638tfmzgtzWwZ2FQvMaaA%3D%3D"}],"group":"cf-nel","max_age":604800}
accept-ranges: bytes
cf-ray: 7ae0aa103e309a18-FRA
x-amz-cf-id: HC1N-yPokb7wc_cd9WHiCRPLDXiBFq3Omqaa4CcmVhKpM1jI4YXuBg==

GET
H3 200 linkedin.jpg
blog.visiblealpha.com/hubfs/Visible_Alpha_April2018/Images/ 524 B
2 KB 50ms
47ms Image
image/webp 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hubfs/Visible_Alpha_April2018/Images/linkedin.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

fd8cfc191b302ef9ac54eba2d3c81dddea4de3956032ef159bb38f1b0fcbe5c7

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-amz-meta-cache-tag: F-5688679884,FD-5688829971,P9snR,FLS
age: 18583
x-amz-request-id: NDCFBHHA300A040J
edge-cache-tag: F-5688679884,FD-5688829971,P9snR,FLS
x-hs-https-only: worker
content-disposition: inline; filename="linkedin.webp"
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
cf-bgj: imgq:85,h2pri
etag: "90d49f54df899271522ea3d3fd022b90"
vary: Accept, Accept-Encoding
access-control-allow-methods: GET
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18
date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 85310f8b6878a9cfaa0218e021ae364e.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: ejqiCweGdClAHFYnhvA5LXHKNLklCh4L
x-amz-cf-pop: FRA56-P7
cf-polished: qual=85, origFmt=jpeg, origSize=878
x-cache: Miss from cloudfront
cache-tag: F-5688679884,FD-5688829971,P9snR,FLS
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 524
x-amz-id-2: ZN1jByajXh/isXaaBfSTRKs/GBgYbz+K80GHhBA3dSpUACiJSDNqRHl6vc925Wlbj4XYPR9V5yEJgTaBi4H+FzDrlyh8kP1PB+WKDji9yrg=
last-modified: Mon, 09 Apr 2018 10:59:59 GMT
server: cloudflare
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=TNAZ87TZHfSF9n7oEfQQm%2Fjii5hgUXCxAOLXJrb6m4V8f1HZpRSt%2FbgPPu1zVyn3Rlw4KJa5zP%2BsXBK07py%2FWfpd4H1t6XLTSTRX7sqfUtyqWuJ0tChqqKSQrPG5xXNAcrKmpHGyqqW4Su2AxRjUyb0qsw%3D%3D"}],"group":"cf-nel","max_age":604800}
accept-ranges: bytes
cf-ray: 7ae0aa103e319a18-FRA
x-amz-cf-id: WrxPeRrh53ILLTM0zjAE2u-WLy98cUCdlbSfLW9HOZtSU58THPdpCw==

GET
H3 200 twitter.jpg
blog.visiblealpha.com/hubfs/Visible_Alpha_April2018/Images/ 392 B
2 KB 48ms
45ms Image
image/webp 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hubfs/Visible_Alpha_April2018/Images/twitter.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

c3bbde9563b10b7ad6c87ac0920bfb7accca58ad9210fd53a370e905a1d1191b

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-amz-meta-cache-tag: F-5688679881,FD-5688829971,P9snR,FLS
age: 18583
x-amz-request-id: 08X5QMB7TC3G0F7A
edge-cache-tag: F-5688679881,FD-5688829971,P9snR,FLS
x-hs-https-only: worker
content-disposition: inline; filename="twitter.webp"
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
cf-bgj: imgq:85,h2pri
etag: "01611abab3f5b87f80deb7647fddbd75"
vary: Accept, Accept-Encoding
access-control-allow-methods: GET
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18
date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 6e5ec1ef7875ec0751cb61200df7f212.cloudfront.net (CloudFront)
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: 43Z55J7YX0ImHFGWR7TQuPufcnFOQ.qB
x-amz-cf-pop: FRA56-P7
cf-polished: qual=85, origFmt=jpeg, origSize=706
x-cache: RefreshHit from cloudfront
cache-tag: F-5688679881,FD-5688829971,P9snR,FLS
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 392
x-amz-id-2: VkB+AIWeLe0BjsQBUr7LJGuEvfwGErGqkqgyaZLxuUCUvdH8IMBs+K+bSpD4lwgwfGHj0gVWBG+owK70ChRmpA==
last-modified: Mon, 09 Apr 2018 10:59:59 GMT
server: cloudflare
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=DPWddDQPW2cI0Z4s%2BTCEs9WbwkxA8dTnizP4nxdBge4%2FmzVwRZ6SEN88Ym4tMAZo5D5%2FzOWXrC58TwCAqFgzCjlP9Y7szpiMEcHKBpQkKbmYHcaLWwQqT84W8vhLtGdes32sICa%2Bv6GbmetsrCNG6RFmcQ%3D%3D"}],"group":"cf-nel","max_age":604800}
accept-ranges: bytes
cf-ray: 7ae0aa103e329a18-FRA
x-amz-cf-id: HqA6vcPAVgF5Z1j3HAvDywZQHZYV0DicRZTaSJEqE6EdI9B7y25jJw==

GET
H3 200 Visible_Alpha_April2018-main.js Show response
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521176/1569931764682/Visible_Alpha_April2018_Theme/Code/js/ 2 KB
1 KB 251ms
247ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521176/1569931764682/Visible_Alpha_April2018_Theme/Code/js/Visible_Alpha_April2018-main.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

232aad7a4d809d0f2dbbe8adf501aa654689137c5d70631562b8af1bcc7382fc

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 a7a1b4c19abc42d237405ce4c4069f10.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: ENvVfMyb305re5lLCYr503fzRBtgAm2Q
x-amz-cf-pop: IAD89-P1
x-amz-request-id: EPWCZ3G66X8E4HWB
content-encoding: br
x-cache: RefreshHit from cloudfront
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 15
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-id-2: 62rkcf+xRpnb20O3wAurGk+toizVPSgKiX/b9fT6euX9t/lRTC9e2gQ2XxVPL2k1DpvdrCUcVVI=
last-modified: Tue, 01 Oct 2019 12:09:25 GMT
server: cloudflare
etag: W/"4ea7f12fe8670d2c8a32315fd26f4ffb"
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=NSQIitt%2Bsou4xFgsLXw1krW09NYhf6rkWXqYMgpC2lFgZEo5a1ZNPZo3LggHoUCaJSc350%2FgEpECpuuOl38TEViS8EaHRUXBqawYb1EbFFIAoQgA3cxH9mti2f71tJ9t4FmkT0hd5CQG5JFqdNxPpCXnOw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
cf-ray: 7ae0aa103e299a18-FRA
x-amz-cf-id: 3lrmFu0gZEQK4LFfQ543-Cog0RaOvYOuLGa_CuD4gCSvvS7buBwmyA==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 15

GET
H3 200 nickel-blog.js Show response
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/6335810317/1569931763127/Nickel_Blog_Theme_2018/Code/js/ 151 B
1 KB 286ms
282ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/6335810317/1569931763127/Nickel_Blog_Theme_2018/Code/js/nickel-blog.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

a8a9b385914438dbe93755b37b6811d05edd7e9f892e254009d8c8204c5480fb

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
via: 1.1 68261aebcfc232344da2ef3bf1d3f9ea.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: z23XafHA5luWOEqLZVWtB6DLseTLshR.
x-amz-cf-pop: IAD89-P1
x-amz-request-id: FR8SKCDFV694JPTQ
content-encoding: br
x-cache: RefreshHit from cloudfront
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 15
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-id-2: CUQYgwYeRDvEfFpFhDV3QYcHPXyzeiIq5xio7+o50p+Hgug4T8QDNHmkzKsYakLqXOxYdXequZA=
last-modified: Tue, 01 Oct 2019 12:09:24 GMT
server: cloudflare
etag: W/"2a1338269fcc619b4c1dcb34c1ad3071"
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=BKVTYR0D5nkl83MOt3K6ofW4JnxDSOsZCHnZM64uAM9BhU7FhJ5ZASBtJjL9aN8gmIQoi69506kErQsnp04c2Rk2QprKMLcpHokM%2FHex5nHWoq7enDj3fevbmsXG8jNuVSEU5HroquU1DasDsYl3RMuiRQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
cf-ray: 7ae0aa103e2b9a18-FRA
x-amz-cf-id: PE_jd151iR8Qu0-DQhtL-_ibsEMzgZeVrxf6tmLJIijEFq4n71J52w==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 15

GET
H3 200 2355593.js Show response
blog.visiblealpha.com/hs/scriptloader/ 1 KB
1 KB 418ms
415ms Script
application/javascript 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/scriptloader/2355593.js

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

1f69b87c22086b705c99c332269d7e92661a3f782361c5d18f90a1fa83787c98

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
content-encoding: br
cf-cache-status: EXPIRED
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: ead29cd2-f6a7-428a-bae5-d809ab965a89
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Sun, 26 Mar 2023 15:51:17 GMT
server: cloudflare
x-trace: 2BFC2A0B3C5803BAA5C6A78272B104093A8BC4A6A8000000000000000000
vary: origin, Accept-Encoding
access-control-max-age: 3600
content-type: application/javascript;charset=utf-8
access-control-allow-origin: https://blog.visiblealpha.com
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=m7eKt%2FMOG8AldE3KYsoxzmfr%2FePzvIS3syrMllZiorV7u1JpTCMm4vjvk9oR1rlOyuvH6svDtTo26gBLJMzrhlUs8YH38ooXgyYeimPpUPiSTh4Buw1dchZOnsduLKSDdplRi3hWoppFp6hcknLxuKr1Nw%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control: public, max-age=60
access-control-allow-credentials: true
cf-ray: 7ae0aa103e349a18-FRA
expires: Sun, 26 Mar 2023 16:11:32 GMT

GET
H2 200 PX6eqp8JJGAXWkAuKxge Show response
ws.zoominfo.com/pixel/ 3 KB
2 KB 249ms
221ms Script
text/javascript 2606:4700::6810:a852
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://ws.zoominfo.com/pixel/PX6eqp8JJGAXWkAuKxge

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:a852 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare / Express

Resource Hash

68faa636e3193ce6c05c55db1b7eadb8c85d33cadec96fa50ac83581af70c5ff

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
via: 1.1 google
server: cloudflare
x-powered-by: Express
vary: Accept-Encoding
content-type: text/javascript
access-control-allow-origin: *
access-control-allow-credentials: true
cf-ray: 7ae0aa108c349237-FRA
access-control-allow-headers: Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for, x-ws-collect-type,requestFromZITag,unifiedScriptVerified,_zitok
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

GET
H2 200 VisibleAlpha_Blog_RT;ord=627676779364.6432
pubads.g.doubleclick.net/activity;dc_iu=/5206/invc.invc/ 42 B
542 B 80ms
43ms Image
image/gif 2a00:1450:4001:806::2002
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://pubads.g.doubleclick.net/activity;dc_iu=/5206/invc.invc/VisibleAlpha_Blog_RT;ord=627676779364.6432?

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

pragma: no-cache
date: Sun, 26 Mar 2023 16:10:32 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control: no-cache, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 css
fonts.googleapis.com/ 10 KB
1 KB 36ms
15ms Stylesheet
text/css 2a00:1450:4001:813::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Open+Sans:300,400,500,700&subset=latin-ext

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5678766005/1679335755348/Nickel_Blog_Theme_2018/Code/css/nickel_2017.min.css

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:813::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

41191d77d044691c96c90990bfe4693775ab4a3aad4ada259c3605d1970052d2

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5678766005/1679335755348/Nickel_Blog_Theme_2018/Code/css/nickel_2017.min.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Sun, 26 Mar 2023 15:42:18 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Sun, 26 Mar 2023 16:10:32 GMT

GET
H2 200 memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
fonts.gstatic.com/s/opensans/v34/ 44 KB
44 KB 27ms
6ms Font
font/woff2 2a00:1450:4001:811::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/opensans/v34/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Open+Sans:300,400,500,700&subset=latin-ext

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:811::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

8778e9af2422858d7052ff9a0f3c12c08ae976bdd6e0316db144cd5579cd97db

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://blog.visiblealpha.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Tue, 21 Mar 2023 08:37:39 GMT
x-content-type-options: nosniff
age: 459173
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 44856
x-xss-protection: 0
last-modified: Mon, 15 Aug 2022 18:20:18 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Wed, 20 Mar 2024 08:37:39 GMT

GET
H2 200 css
fonts.googleapis.com/ 26 KB
1 KB 16ms
15ms Stylesheet
text/css 2a00:1450:4001:813::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Open+Sans:300,300i,400,400i,600,600i,700,700i,800,800i

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521177/1661441551520/Visible_Alpha_April2018_Theme/Code/css/Visible_Alpha_April2018-style.min.css

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:813::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

47a7dd0cada3c63b3d5981848b65973772a3f5ccc578d16ed90e3aa1b74056ab

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521177/1661441551520/Visible_Alpha_April2018_Theme/Code/css/Visible_Alpha_April2018-style.min.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Sun, 26 Mar 2023 14:25:00 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Sun, 26 Mar 2023 16:10:32 GMT

GET
H2 200 font-awesome.min.css
stackpath.bootstrapcdn.com/font-awesome/4.7.0/css/ 30 KB
7 KB 47ms
18ms Stylesheet
text/css 2606:4700::6812:acf
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://stackpath.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:acf , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

799aeb25cc0373fdee0e1b1db7ad6c2f6a0e058dfadaa3379689f583213190bd

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521177/1661441551520/Visible_Alpha_April2018_Theme/Code/css/Visible_Alpha_April2018-style.min.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: br
cdn-edgestorageid: 617
age: 6006222
cdn-cachedat: 2021-06-08 14:35:32
cdn-pullzone: 252412
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Mon, 25 Jan 2021 22:04:55 GMT
server: cloudflare
cdn-requestpullcode: 200
vary: Accept-Encoding
content-type: text/css; charset=utf-8
cdn-cache: HIT
access-control-allow-origin: *
cdn-uid: b1941f61-b576-4f40-80de-5677acb38f74
cache-control: public, max-age=31919000
cdn-requestid: 8e03a0f40ac23c08b1fbc5b05ccb27fd
timing-allow-origin: *
cdn-requestcountrycode: US
cf-ray: 7ae0aa10bc66bb37-FRA
cdn-requestpullsuccess: True

GET
H2 200 css2
fonts.googleapis.com/ 1 KB
542 B 15ms
15ms Stylesheet
text/css 2a00:1450:4001:813::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css2?family=PT+Sans:wght@700&display=swap

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:813::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

59ac3ecd95747ba38da3be75c4d011fa4f2036b058c2ade90de152c61a7d625f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/5688521177/1661441551520/Visible_Alpha_April2018_Theme/Code/css/Visible_Alpha_April2018-style.min.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 0
last-modified: Sun, 26 Mar 2023 15:30:29 GMT
server: ESF
cross-origin-opener-policy: same-origin-allow-popups
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires: Sun, 26 Mar 2023 16:10:32 GMT

GET
H2 200 va-home-bg2.jpg
2355593.fs1.hubspotusercontent-na1.net/hubfs/2355593/ 86 KB
87 KB 868ms
868ms Image
image/jpeg 2606:4700:4400::ac40:9ad8
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://2355593.fs1.hubspotusercontent-na1.net/hubfs/2355593/va-home-bg2.jpg
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/template_assets/6297554256/1666101947735/Nickel_Blog_Theme_2018/Code/css/nickel-custom.min.css
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:4400::ac40:9ad8 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 82106184ed49690d85714387058c0e46b71bb8f302b182ebd13877f0fb33e1da

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-amz-meta-cache-tag: F-82499078949,P-2355593,FLS-ALL
x-amz-request-id: 54A78663FH1D9T5N
x-amz-server-side-encryption: AES256
edge-cache-tag: F-82499078949,P-2355593,FLS-ALL
x-amz-replication-status: COMPLETED
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 18
etag: "5e3036b96d4e4babf107251135922f44"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: image/jpeg
access-control-allow-origin: *
x-amz-meta-created-unix-time-millis: 1660946706976
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
x-robots-tag: all
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 18
date: Sun, 26 Mar 2023 16:10:33 GMT
via: 1.1 62e7b24ca032b612bb93fa7f3437469c.cloudfront.net (CloudFront)
cf-cache-status: MISS
x-amz-version-id: pAOyPF15CagWPzCyL.6W5EAKKIbiJwUl
x-amz-cf-pop: FRA56-P7
x-hs-alternate-content-type: text/plain
x-cache: RefreshHit from cloudfront
cache-tag: F-82499078949,P-2355593,FLS-ALL
x-amz-meta-index-tag: all
x-amz-storage-class: INTELLIGENT_TIERING
content-length: 88286
x-amz-id-2: 4AIuz2WhP9k6RSions4saTJzn40v9zeg4AGWEuYX6AUCRIi5O7QZ0zVJZwWmAkNWU+I1oPb8pt51hb+lhfZqtw==
last-modified: Fri, 19 Aug 2022 22:05:08 GMT
server: cloudflare
accept-ranges: bytes
cf-ray: 7ae0aa10fd8f39e5-FRA
x-amz-cf-id: rhw3mqTuKoApS8xJRmu982Dw1aYoS8ZLAsUrd908OEiPXa33Yobq8Q==

GET
H2 200 jizfRExUiTo99u79B_mh0O6tLQ.woff2
fonts.gstatic.com/s/ptsans/v17/ 46 KB
46 KB 11ms
9ms Font
font/woff2 2a00:1450:4001:811::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/ptsans/v17/jizfRExUiTo99u79B_mh0O6tLQ.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=PT+Sans:wght@700&display=swap

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:811::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

141f0c53e457585d4ac7426eb3d757666d250ee6fbf0e9c0878128e4c627f0b1

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://blog.visiblealpha.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Tue, 21 Mar 2023 08:37:50 GMT
x-content-type-options: nosniff
age: 459162
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 47048
x-xss-protection: 0
last-modified: Wed, 27 Apr 2022 16:55:54 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Wed, 20 Mar 2024 08:37:50 GMT

GET
H2 200 memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2
fonts.gstatic.com/s/opensans/v34/ 47 KB
47 KB 7ms
6ms Font
font/woff2 2a00:1450:4001:811::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/opensans/v34/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6F.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Open+Sans:300,300i,400,400i,600,600i,700,700i,800,800i

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:811::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

84161c46238fff2c6920ebc28f02cddd7b710cf3d1107853f540b084320f6afd

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://fonts.googleapis.com/
Origin: https://blog.visiblealpha.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Tue, 21 Mar 2023 08:37:40 GMT
x-content-type-options: nosniff
age: 459172
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 47952
x-xss-protection: 0
last-modified: Mon, 15 Aug 2022 18:22:41 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Wed, 20 Mar 2024 08:37:40 GMT

GET
H3 200 fontawesome-webfont.woff2
stackpath.bootstrapcdn.com/font-awesome/4.7.0/fonts/ 75 KB
76 KB 34ms
20ms Font
font/woff2 2606:4700::6812:acf
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://stackpath.bootstrapcdn.com/font-awesome/4.7.0/fonts/fontawesome-webfont.woff2?v=4.7.0

Requested by

Host: stackpath.bootstrapcdn.com
URL: https://stackpath.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700::6812:acf , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2adefcbc041e7d18fcf2d417879dc5a09997aa64d675b7a3c4b6ce33da13f3fe

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://stackpath.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css
Origin: https://blog.visiblealpha.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
cdn-edgestorageid: 752
age: 126582
cdn-cachedat: 08/17/2022 18:20:14
cdn-pullzone: 252412
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 77160
last-modified: Mon, 25 Jan 2021 22:04:55 GMT
cdn-proxyver: 1.02
cdn-requestpullcode: 200
server: cloudflare
etag: "af7ae505a9eed503f8b8e6982036873e"
vary: Accept-Encoding
content-type: font/woff2
access-control-allow-origin: *
cdn-cache: HIT
cdn-uid: b1941f61-b576-4f40-80de-5677acb38f74
cache-control: public, max-age=31919000
cdn-requestid: 34c372309231eb1d8961a9cb29f05c58
accept-ranges: bytes
timing-allow-origin: *
cdn-requestcountrycode: DE
cdn-status: 200
cf-ray: 7ae0aa110d6439bc-FRA
cdn-requestpullsuccess: True

GET
H3 200 VA-Doc-FDA-Approved-Drugs-2022-%26-Select-Consensus-Revs-032023-v2.jpg
blog.visiblealpha.com/hs-fs/hubfs/ 183 KB
184 KB 1517ms
1517ms Image
image/jpeg 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hs-fs/hubfs/VA-Doc-FDA-Approved-Drugs-2022-%26-Select-Consensus-Revs-032023-v2.jpg?width=870&height=1108&name=VA-Doc-FDA-Approved-Drugs-2022-%26-Select-Consensus-Revs-032023-v2.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

940a87b1598a22a13a1eb9d7852c086acf6b71bfd63f5a852f9217a7b1cf014f

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
via: 1.1 61e929f79f2623281d7e3a91da354352.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'
cache-tag: F-107264538180,P-2355593,FLS-ALL
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 187709
cf-resized: internal=ok/m q=0 n=951+0 c=11+490 v=2023.3.5 l=187709
last-modified: Mon, 20 Mar 2023 21:46:52 GMT
cf-bgj: imgq:85,h2pri
server: cloudflare
etag: "cfEjNYQeK15BrYzSFc9EWyk_W3FBVwboYD1cbj3JsADQ:d0cb67e223db4601dd0db6d811dc01a8"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nLO0Ku4l9qc5pyo4uvUTFiExvCknWHZ8NgelruTOo2toFpd8B3fhbIaU0Nyb%2FUA0J2gZH0VSDKf%2Bn8mAvPM9%2FoGfMiYVtUwVGJvembdSjxoW%2Bnqj23HNUIoxVoDM3SJ%2BLQAAnClxQGJFJsCAl360hxv%2FlQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
access-control-allow-origin: *
cache-control: max-age=1209600, s-maxage=1814400, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 7ae0aa113f8e9a18-FRA

GET
H3 200 fda-chart-cta-1.jpg
blog.visiblealpha.com/hs-fs/hubfs/ 51 KB
52 KB 953ms
953ms Image
image/jpeg 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hs-fs/hubfs/fda-chart-cta-1.jpg?width=793&height=244&name=fda-chart-cta-1.jpg

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

2f3a2438b0e7fc101d30668ae3825d6a3f9f4583d98b7e1c998598b98a4a7f97

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
via: 1.1 fd1922963c91836bd3bc6df1671c0612.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'
cache-tag: F-106977789804,P-2355593,FLS-ALL
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 52334
cf-resized: internal=ok/m q=0 n=883+0 c=2+0 v=2023.3.5 l=52334
last-modified: Fri, 17 Mar 2023 21:23:36 GMT
cf-bgj: imgq:0,h2pri
server: cloudflare
etag: "cfWlkIh6d6Sy1HFVoOwuHXGnScuikDMolizkRv6j46DQ:0260ce7d11e16f91eb38821af65702d4"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=UjYv7Ysw1UuFqt94crf4hJdu%2BZIcwiBFkyNHDDQoCVPRs2XVtkJZXvTRGpUc9Ba%2F0Biaqjqo3MdQgvRFuABI29%2FI%2Fml5Ak%2FJLIjao1e%2BcOXnL%2B%2BeVMrSpJfT%2FuUH5KE62jbpziy4XOBslOFy8czagzO9ZA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
access-control-allow-origin: *
cache-control: max-age=1209600, s-maxage=1814400, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 7ae0aa113f909a18-FRA

GET
H3 200 json Show response
blog.visiblealpha.com/_hcms/forms/embed/v3/form/2355593/57098b06-4f8f-4c07-a61a-bf90a0b619cb/ 16 KB
4 KB 165ms
164ms XHR
application/json 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/_hcms/forms/embed/v3/form/2355593/57098b06-4f8f-4c07-a61a-bf90a0b619cb/json?hs_static_app=forms-embed&hs_static_app_version=1.2916&X-HubSpot-Static-App-Info=forms-embed-1.2916

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/_hcms/forms/v2.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

8e6a603dfafdf106a2fb9aa6159fa2a06c106119749e43595f27e4563e9793c2

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

Accept: application/json, text/plain, */*
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-origin-hublet: na1
date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000
content-encoding: br
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: 4049edec-059d-458c-a124-6f1c5047dbab
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
server: cloudflare
x-trace: 2BEF3935A802F315779C74EA158EB1DA701BCFA0F4000000000000000000
vary: origin, Accept-Encoding
access-control-allow-methods: OPTIONS, GET
content-type: application/json;charset=utf-8
access-control-max-age: 180
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=vuJ1QY9OMixKrct8t5kj2xRr4IQ6pCg2AooFMHVoHQ5D%2BUwF5Jb0TwTW%2FwMPOZsV8Uj2iIRrL%2FXfhbTS%2B3dvggrtvB081mxf4CDVbNUse45Wc4%2BoeTmUhXwA3YCZ%2Bgbd0GU1S1aLh%2FXfPBu1PjJsUUW5nw%3D%3D"}],"group":"cf-nel","max_age":604800}
access-control-expose-headers: X-Origin-Hublet
cache-control: max-age=0, no-cache, no-store
access-control-allow-credentials: false
cf-ray: 7ae0aa1228b89a18-FRA
access-control-allow-headers: *
x-robots-tag: none

GET
H/1.1 200
OK widgets.js Show response
platform.twitter.com/ 91 KB
28 KB 75ms
12ms Script
application/javascript 2606:2800:234:59:254c:406:2366:268c
EDGECAST

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets.js
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 2606:2800:234:59:254c:406:2366:268c , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software: ECS (amb/6BA1) /
Resource Hash: 392c9fa9cd1273a2a89d1a83a69cd1f63f21d1d55e7be21e1d8f51f25145668b

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Date: Sun, 26 Mar 2023 16:10:32 GMT
Content-Encoding: gzip
Age: 23
x-amz-server-side-encryption: AES256
X-Cache: HIT
P3P: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server-Timing: x-cache;desc= HIT,x-tw-cdn;desc=VZ
Content-Length: 27630
Last-Modified: Tue, 24 Jan 2023 21:41:51 GMT
Server: ECS (amb/6BA1)
Etag: "9e99725b7a4cd730a934afba2a438bb5+gzip"
Access-Control-Max-Age: 3000
Access-Control-Allow-Methods: GET
Content-Type: application/javascript; charset=utf-8
Access-Control-Allow-Origin: *
x-tw-cdn: VZ
Cache-Control: public, max-age=1800
Vary: Accept-Encoding

GET
H2 204 has-permission Show response
app.hubspot.com/content-tools-menu/api/v1/tools-menu/ 0
409 B 216ms
205ms Script
text/plain 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://app.hubspot.com/content-tools-menu/api/v1/tools-menu/has-permission?portalId=2355593&callback=jsonpHandler

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs/hsstatic/HubspotToolsMenu/static-1.154/js/index.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: DYNAMIC
x-hs-worker-debug-mode: false
server: cloudflare
x-hubspot-correlation-id: 3485d925-67d8-4130-bca3-ee4e4c771397
x-trace: 2B3E12EF75560225297B1AA51F08644BD6906C61C9000000000000000000
vary: origin, Accept-Encoding
access-control-allow-methods: GET
report-to: {"group":"default","max_age":86400,"endpoints":[{"url":"https://exceptions.hubspot.com/csp/reports"}]}
cache-control: max-age=0
access-control-allow-credentials: true
cf-ray: 7ae0aa124e98bbfd-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
reporting-endpoints: default="https://exceptions.hubspot.com/csp/reports?cfRay=7ae0aa124e98bbfd&resource=unknown"

GET
H2 200 public Show response
api-na1.hubapi.com/comments/v3/comments/thread/ 75 B
718 B 164ms
135ms Script
application/javascript 2606:4700::6811:cccc
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://api-na1.hubapi.com/comments/v3/comments/thread/public?portalId=2355593&offset=0&limit=1000&contentId=106512198193&collectionId=4226313608&callback=jsonp_1679847032681_13944

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs/hsstatic/AsyncSupport/static-1.122/js/comment_listing_asset.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:cccc , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4ab7ec84d04b7581c143ca928faed09fb9b82ad0920bbd7abdcc521fe9ce82e6

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: br
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server: cloudflare
x-hubspot-correlation-id: e03228f9-f5d3-4e67-b085-55dd62449947
x-trace: 2BABAE5530F790EC11B2D50BF0CD25FC87FBBDD5E6000000000000000000
vary: origin
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=crOmssFJYsKjOOYIymny8CZrbv0MjkkWIoMgYoWc%2FqK7KfblYAgZsXsdJKw7CBuUucN0uUA%2BOqJhJzDpbpujteqI73nkOVWRlEQK8nbUlwwvn0ZlIEejWkZrV3WcUvSI1SWxkafmful%2FSREBi8TBcw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=utf-8
access-control-allow-credentials: false
cf-ray: 7ae0aa127a226927-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

GET
H2 200 cta-json Show response
cta-service-cms2.hubspot.com/ctas/v2/public/cs/ 3 KB
2 KB 497ms
487ms XHR
application/json 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cta-service-cms2.hubspot.com/ctas/v2/public/cs/cta-json?canon=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&pageId=106512198193&pid=2355593&sv=cta-embed-js-static-1.140&rdy=1&cos=1&df=t&pg=8694811b-cee5-48c6-878f-b29131776884

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs/cta/cta/current.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

24ca758e8b6aa3f7f280981805947c5bb964d166b263303ce5d45d2b0bf21d2e

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-origin-hublet: na1
date: Sun, 26 Mar 2023 16:10:33 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: br
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: 81f88724-b764-4973-9a96-0749e53a8223
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
server: cloudflare
x-trace: 2BA615F160B5BA32596CC954159466EE1DA3239816000000000000000000
vary: origin
access-control-allow-methods: OPTIONS, GET
content-type: application/json;charset=utf-8
access-control-allow-origin: https://blog.visiblealpha.com
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=KaL6ZH7%2FdIftvXM6FExCpbdL3hIOI6DuYq%2FTm1UwMA06NqpXIg7Br8n%2FkPeDZU%2Bm%2FNXom5wG%2Bl%2FyD1047sZ3m9dSEWyEHQ81OzcckiE8uJ9M91LPW2XfBjQ1uO88z53Cf5li3wrVAj%2B4gTmAlsoabrylieZOu53%2Ba2k%3D"}],"group":"cf-nel","max_age":604800}
access-control-expose-headers: X-Origin-Hublet
cache-control: max-age=0, no-cache, no-store
access-control-allow-credentials: true
access-control-max-age: 180
x-robots-tag: noindex, follow
access-control-allow-headers: Accept, Accept-Charset, Accept-Encoding, Accept-Language, Content-Type, Host, Origin, Referer, User-Agent
cf-ray: 7ae0aa125eb3bbfd-FRA

GET
H/1.1 200
OK widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html Show response
platform.twitter.com/widgets/ Frame 1FA3 320 KB
104 KB 12ms
12ms Document
text/html 2606:2800:234:59:254c:406:2366:268c
EDGECAST

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets/widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html?origin=https%3A%2F%2Fblog.visiblealpha.com
Requested by: Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 2606:2800:234:59:254c:406:2366:268c , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software: ECS (amb/6B94) /
Resource Hash: 4002d65e95f94dc87ae8ad170eb8dbc3644921032ac76dcb376537d9304a6fbf

Request headers

Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

Access-Control-Allow-Methods: GET
Access-Control-Allow-Origin: *
Age: 933466
Cache-Control: public, max-age=315360000
Content-Encoding: gzip
Content-Length: 105435
Content-Type: text/html; charset=utf-8
Date: Sun, 26 Mar 2023 16:10:32 GMT
Etag: "95e1b50b0c179aefb47b5b211bb347b5+gzip"
Last-Modified: Tue, 24 Jan 2023 21:41:13 GMT
P3P: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server: ECS (amb/6B94)
Server-Timing: x-cache;desc= HIT,x-tw-cdn;desc=VZ
Vary: Accept-Encoding
X-Cache: HIT
x-amz-server-side-encryption: AES256
x-tw-cdn: VZ

GET
H2 200 2355593.js Show response
js.hs-analytics.net/analytics/1679847000000/ 65 KB
21 KB 174ms
147ms Script
text/javascript 2606:4700::6811:47b0
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://js.hs-analytics.net/analytics/1679847000000/2355593.js
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs/scriptloader/2355593.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6811:47b0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 202d0a3405220394b116d2181f01b58322a78a746ab774012ecfcf8dc3eea1e6

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
x-amz-version-id: null
content-encoding: br
cf-cache-status: MISS
x-amz-request-id: 4SHRNZ9EQHPPD0PS
x-amz-server-side-encryption: AES256
x-amz-id-2: Gf+8YxqhrwPKguc3WnKM/QnQYyUTuXGGIkZYINM20tmLKy2fKiatuqOJ4pufgAdRMuzSBN+eUEE=
last-modified: Thu, 23 Mar 2023 16:31:19 GMT
server: cloudflare
etag: W/"5215ad0c8141426845e70b2b09cc9749"
vary: origin, Accept-Encoding
content-type: text/javascript
cache-control: max-age=300, public
access-control-allow-credentials: false
cf-ray: 7ae0aa12f884bbcd-FRA
expires: Sun, 26 Mar 2023 16:15:32 GMT

GET
H2 200 leadflows.js Show response
js.hsleadflows.net/ 545 KB
87 KB 209ms
185ms Script
application/javascript 2606:4700::6811:eacc
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://js.hsleadflows.net/leadflows.js
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs/scriptloader/2355593.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6811:eacc , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: fab06beda6c8c452e25e0adee818c31d7fb0b8381d370d3dcbb9d62ec8107860

Request headers

Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Origin: https://blog.visiblealpha.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:32 GMT
x-amz-version-id: waE9SUXeTvXi6sWFWRT4B49N3dJ8yImu
via: 1.1 c3d335addde48969fafe25d4064cee80.cloudfront.net (CloudFront)
cf-cache-status: MISS
content-encoding: br
x-amz-cf-pop: IAD12-P3
x-amz-server-side-encryption: AES256
content-security-policy-report-only: frame-ancestors 'self'; report-uri https://exceptions.hubspot.com/csp/report?resource=lead-flows-js/static-1.1163/bundle/main/lead-flows-release.js&cfRay=7ae0aa12fd215c32-IAD
x-cache: RefreshHit from cloudfront
cache-tag: staticjsapp-lead-flows-cloudflare-web-prod,staticjsapp-prod
x-amz-replication-status: COMPLETED
last-modified: Thu, 02 Mar 2023 09:43:53 UTC
server: cloudflare
etag: W/"15b55a577dac25b07b6c519f5d1a3aec"
access-control-max-age: 3000
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
x-hs-cache-status: MISS
vary: Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
cache-control: s-maxage=86400, max-age=0
cf-ray: 7ae0aa12fd215c32-FRA
x-amz-cf-id: nu4gk_VBEd6g-FkHvyp8q8Sq8guxhkkcli1-2-eS7uIb-TjFdJwyiw==
x-hs-target-asset: lead-flows-js/static-1.1163/bundle/main/lead-flows-release.js

GET
H2 200 2355593.js Show response
js.hs-banner.com/ 63 KB
16 KB 438ms
407ms Script
text/javascript 2606:4700:4400::6812:21ab
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://js.hs-banner.com/2355593.js
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs/scriptloader/2355593.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:4400::6812:21ab , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: c750fcf27d5c438e165ab53b815b19c82aee807d151026d5ed302c267719bd20

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
x-amz-version-id: pjuvlg6AwGXMTcq6F0L3dQE0ECV48nQB
content-encoding: br
cf-cache-status: REVALIDATED
x-amz-request-id: M8HY1EVTWRB5C13Q
x-amz-server-side-encryption: AES256
x-amz-id-2: FH8xlvpTQAFGCj8sidAtwUaQpBCw0AyG2AMW/TL2JsziZa7ZqcqvvDSzmlJGEgQ0QAr/KFpZs2U=
last-modified: Mon, 06 Mar 2023 20:16:40 GMT
server: cloudflare
etag: W/"7227bf5a6ab38dca3340ce532842cacf"
access-control-max-age: 604800
access-control-allow-methods: GET, OPTIONS, PUT, POST, DELETE, PATCH, HEAD
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: https://visiblealpha.com
access-control-expose-headers: x-last-modified-timestamp, X-HubSpot-NotFound, X-HS-User-Request, Link, Server-Timing
cache-control: max-age=300, public
access-control-allow-credentials: true
vary: origin, Accept-Encoding
timing-allow-origin: *
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Accept-Charset, Accept-Encoding, X-Override-Internal-Permissions, X-Properties-Source, X-Properties-SourceId, X-Properties-Flag, X-Hubspot-User-Id, X-Hubspot-Trace, X-Hubspot-Callee, X-Hubspot-Offset, X-Hubspot-No-Trace, X-HubSpot-Static-App-Info, X-HubSpot-Messages-Uri, X-HubSpot-Request-Source, X-HubSpot-Request-Reason, Subscription-Billing-Auth-Token, X-App-CSRF, X-Tools-CSRF, Online-Payment-Signing-UUID, X-Source, X-SourceId, X-Origin-UserId, X-Biden-Request-Source, X-HubSpot-CSRF-hubspotapi, X-Force-Cookie-Refresh, X-Force-Cookie-Refresh-No-Cache, X-HS-User-Request, X-Application-Id, X-HS-Referer, X-HubSpot-Correlation-Id
cf-ray: 7ae0aa130cda03c4-FRA
expires: Sun, 26 Mar 2023 16:15:33 GMT

GET
H2 200 settings Show response
syndication.twitter.com/ Frame 1FA3 663 B
605 B 210ms
135ms Fetch
application/json 104.244.42.200
TWITTER

General

Check archive.org

Show headers Download Go to

Full URL

https://syndication.twitter.com/settings?session_id=68241d97b6665ff739eabe97abdde637c5816907

Requested by

Host: platform.twitter.com
URL: https://platform.twitter.com/widgets/widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html?origin=https%3A%2F%2Fblog.visiblealpha.com

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.244.42.200 , United States, ASN13414 (TWITTER, US),

Reverse DNS

Software

tsa_o /

Resource Hash

92747742b0d05de841880d3cad6550593fa08692d26fe086e15d4a5696606a54

Security Headers

Name	Value
Strict-Transport-Security	max-age=631138519

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://platform.twitter.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-response-time: 109
date: Sun, 26 Mar 2023 16:10:32 GMT
content-encoding: gzip
strict-transport-security: max-age=631138519
last-modified: Sun, 26 Mar 2023 16:10:32 GMT
server: tsa_o
vary: Origin
content-type: application/json; charset=utf-8
access-control-allow-origin: https://platform.twitter.com
x-transaction-id: 94eeff3c12b10892
cache-control: must-revalidate, max-age=600
access-control-allow-credentials: true
perf: 7626143928
x-connection-hash: 6fbabef6340205600b684964f5316e30f018131d8854a2efd87a79957b890112
content-length: 284

GET
H/1.1 200
OK counters.gif
forms.hsforms.com/embed/v3/ 35 B
667 B 168ms
140ms Image
image/gif 2606:4700::6810:5605
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://forms.hsforms.com/embed/v3/counters.gif?key=forms-embed-v2-DEFINITION_SUCCESS&count=1

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:5605 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Date: Sun, 26 Mar 2023 16:10:33 GMT
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload
CF-Cache-Status: DYNAMIC
X-HubSpot-Correlation-Id: ce272b03-5a26-46ae-984e-cecb6fb06fb7
Connection: keep-alive
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
Content-Length: 35
Server: cloudflare
X-Trace: 2B99DCDAE068252D6BDA91D73DEAC1FCBEC630555A000000000000000000
Vary: origin
Content-Type: image/gif
Access-Control-Expose-Headers: X-Origin-Hublet
Cache-Control: max-age=0, no-cache, no-store
Access-Control-Allow-Credentials: false
X-Robots-Tag: none
CF-RAY: 7ae0aa138920917c-FRA

GET
H/1.1 200
OK counters.gif
forms-na1.hsforms.com/embed/v3/ 35 B
667 B 425ms
392ms Image
image/gif 2606:4700::6810:5805
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://forms-na1.hsforms.com/embed/v3/counters.gif?key=forms-embed-v2-RENDER_SUCCESS&count=1

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:5805 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Date: Sun, 26 Mar 2023 16:10:33 GMT
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload
CF-Cache-Status: DYNAMIC
X-HubSpot-Correlation-Id: edece7a5-3d2c-4553-a2e1-a2e657ba1f97
Connection: keep-alive
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
Content-Length: 35
Server: cloudflare
X-Trace: 2BD6F5140DE3C65EF01F2BCDC0019FFCA853EAD6EC000000000000000000
Vary: origin
Content-Type: image/gif
Access-Control-Expose-Headers: X-Origin-Hublet
Cache-Control: max-age=0, no-cache, no-store
Access-Control-Allow-Credentials: false
X-Robots-Tag: none
CF-RAY: 7ae0aa13c83b2c6b-FRA

GET
H3 200 cta-loaded.js Show response
blog.visiblealpha.com/hs/cta/ctas/v2/public/cs/ 0
857 B 226ms
225ms Script
text/plain 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/hs/cta/ctas/v2/public/cs/cta-loaded.js?pid=2355593&pg=8694811b-cee5-48c6-878f-b29131776884&lt=1679847032459&dt=1679847032460&at=1679847033185&ae=1&an=1

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/hs/cta/cta/current.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-origin-hublet: na1
date: Sun, 26 Mar 2023 16:10:33 GMT
strict-transport-security: max-age=31536000
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: 2592d8a1-12a8-45f5-a0a0-0a7f41cb500e
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified: Sun, 26 Mar 2023 16:10:33 GMT
server: cloudflare
x-trace: 2BABD7AD2E84CED3CE626F3212DEE0EFEE901B5452000000000000000000
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=076OjlcscrCqOZvO9wLNZt%2FWlAjZ4Tsu7gjl43A%2F%2FUvTwIvuArRJ7lnEcnzDpd2dCVw83Gv8TDAUQ0DuS166%2Biy7HvYgZ2%2F4P2guZEzEqYHGD%2FwJOgRBD44IPf58zqh1fkE%2Fn6E%2FgVAahftWQsWvSJh21w%3D%3D"}],"group":"cf-nel","max_age":604800}
access-control-expose-headers: X-Origin-Hublet
cache-control: max-age=0, no-cache, no-store
cf-ray: 7ae0aa157d2e9a18-FRA
x-robots-tag: noindex, follow

GET
H/1.1 200
OK counters.gif
perf.hsforms.com/embed/v3/ 35 B
749 B 152ms
124ms Image
image/gif 2606:4700::6810:5705
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://perf.hsforms.com/embed/v3/counters.gif?key=cta-json-success&value=1

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:5705 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Date: Sun, 26 Mar 2023 16:10:33 GMT
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload
CF-Cache-Status: MISS
X-HubSpot-Correlation-Id: 122d9fa5-a170-455e-aa3a-94214e0413bc
Connection: keep-alive
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
Content-Length: 35
Last-Modified: Sun, 26 Mar 2023 16:10:33 GMT
Server: cloudflare
X-Trace: 2B2FB91539094CA83E93E14933609EDD5C04891B58000000000000000000
Vary: origin, Accept-Encoding
Content-Type: image/gif
Access-Control-Expose-Headers: X-Origin-Hublet
Cache-Control: max-age=0, no-cache, no-store
Access-Control-Allow-Credentials: false
Accept-Ranges: bytes
X-Robots-Tag: none
CF-RAY: 7ae0aa15995fbb49-FRA

GET
H3 200 5a1ede6b-f428-4704-af58-0435d3424afc.png
blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/resized/ 265 KB
266 KB 301ms
300ms Image
image/png 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://blog.visiblealpha.com/hs-fs/hub/2355593/hub_generated/resized/5a1ede6b-f428-4704-af58-0435d3424afc.png

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

0ebd2ded8c705a2bfaf2a0b7fbdce1608f10256cb30358c8ebaac17833aa6f7a

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
strict-transport-security: max-age=31536000
via: 1.1 126bc2e5c4c1b9ac0ffa004edc6f02c4.cloudfront.net (CloudFront)
cf-cache-status: MISS
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-amz-version-id: 9Br6RKzGLteMFJAccf0gsrENLDGXu6kx
x-amz-cf-pop: IAD89-P1
x-amz-request-id: F5F1EVCEP32KGVG2
x-cache: RefreshHit from cloudfront
x-hs-https-only: worker
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 15
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 271462
x-amz-id-2: JsdbziaX+dcqSpdjPbgQBc2DEoV0ek/ydCKoXEP5RdDNj/vndEBxChX+ctnCQ3GEPj4HIGuKJGI=
last-modified: Tue, 18 Dec 2018 21:47:12 GMT
server: cloudflare
etag: "2d8fcc01b56f82b641f8dea4a39cbfb4"
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=g07xO3Fmj7vPALdqbPFdO9BqfV5di4AQlHpDqONuSxu6EFPlbg7ZBCyDFtX7BX40M3jjNYYsK3L6pkrl10hh5T1K0QFE%2FVzm%2FKLEs%2BGmRPGHyK4NMRUrPSlmtAQ4wTKdVaDb9v7h4Bm0Qg2OwtSDwVui4Q%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/png
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900, s-maxage=31536000, max-age=31536000
access-control-allow-credentials: false
accept-ranges: bytes
cf-ray: 7ae0aa157d339a18-FRA
x-amz-cf-id: qKqpwcLH6Bv1JzwYrKlkcbVgzUbXSqoL70kY4QBUjIif4fAuaQXkyQ==
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 15

GET
H/1.1 200
OK counters.gif
perf.hsforms.com/embed/v3/ 35 B
749 B 154ms
127ms Image
image/gif 2606:4700::6810:5705
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://perf.hsforms.com/embed/v3/counters.gif?key=cta-render-success&value=1

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:5705 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Date: Sun, 26 Mar 2023 16:10:33 GMT
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload
CF-Cache-Status: MISS
X-HubSpot-Correlation-Id: bf15f4a6-0d96-48a7-b38d-cdf209f515dd
Connection: keep-alive
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
Content-Length: 35
Last-Modified: Sun, 26 Mar 2023 16:10:33 GMT
Server: cloudflare
X-Trace: 2B8B4DBFBCBDF2AF19B37E78E5889A8B05CB8B5FF6000000000000000000
Vary: origin, Accept-Encoding
Content-Type: image/gif
Access-Control-Expose-Headers: X-Origin-Hublet
Cache-Control: max-age=0, no-cache, no-store
Access-Control-Allow-Credentials: false
Accept-Ranges: bytes
X-Robots-Tag: none
CF-RAY: 7ae0aa159e8f9165-FRA

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 176 KB
64 KB 54ms
34ms Script
application/javascript 2a00:1450:4001:813::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-P7WQNK9

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:813::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

52d73ca21075c8c365a25dbce63514e10c41e7211ebe5f76f359cb064adf78f3

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 65418
x-xss-protection: 0
last-modified: Sun, 26 Mar 2023 15:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Sun, 26 Mar 2023 16:10:33 GMT

GET
H2 200 analytics.js Show response
www.google-analytics.com/ 49 KB
20 KB 36ms
6ms Script
text/javascript 2a00:1450:4001:810::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-P7WQNK9

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

5971b095cff574a66d35ada016d4c077c86e2dea62e9c0f14cf7c94b258619de

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
date: Sun, 26 Mar 2023 16:05:11 GMT
last-modified: Tue, 10 Jan 2023 21:29:14 GMT
server: Golfe2
age: 322
vary: Accept-Encoding
content-type: text/javascript
cache-control: public, max-age=7200
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 20085
expires: Sun, 26 Mar 2023 18:05:11 GMT

GET
H2 200 insight.min.js Show response
snap.licdn.com/li.lms-analytics/ 13 KB
5 KB 103ms
25ms Script
application/x-javascript 2a02:26f0:480:e::210:f108
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://snap.licdn.com/li.lms-analytics/insight.min.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-P7WQNK9

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:480:e::210:f108 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

Software

Resource Hash

f56ccb2db87aacedd9415232e40f80bff9939703df2f9c3f9ec8a092e545349f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 10 Jan 2023 17:22:56 GMT
x-cdn: AKAM
vary: Accept-Encoding
content-type: application/x-javascript;charset=utf-8
cache-control: max-age=48642
accept-ranges: bytes
content-length: 4777

GET
H2 200 uwt.js Show response
static.ads-twitter.com/ 56 KB
15 KB 53ms
8ms Script
application/javascript 146.75.116.157
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://static.ads-twitter.com/uwt.js
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-P7WQNK9
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 146.75.116.157 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash: cf7fcc9f75c8717897bfaef72f303fab423ce1b70c98512aeb3677e4af988dee

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
content-encoding: gzip
last-modified: Thu, 27 Oct 2022 16:56:53 GMT
etag: "32ad004436155ec972bc50e6238b5b67+gzip+gzip"
vary: Accept-Encoding,Host
x-cache: HIT, HIT
content-type: application/javascript; charset=utf-8
p3p: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
x-tw-cdn: FT
cache-control: no-cache
accept-ranges: bytes
content-length: 15375
x-served-by: cache-iad-kjyo7100081-IAD, cache-fra-eddf8230053-FRA

GET
H2 200 PX6eqp8JJGAXWkAuKxge Show response
ws.zoominfo.com/pixel/ 3 KB
1 KB 170ms
168ms Script
text/javascript 2606:4700::6810:a852
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://ws.zoominfo.com/pixel/PX6eqp8JJGAXWkAuKxge

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:a852 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare / Express

Resource Hash

b5750409a4abe074b96f83cf51f66d9aee77756804d5d890d71f7feaee4629c6

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
via: 1.1 google
server: cloudflare
x-powered-by: Express
vary: Accept-Encoding
content-type: text/javascript
access-control-allow-origin: *
access-control-allow-credentials: true
cf-ray: 7ae0aa164f239237-FRA
access-control-allow-headers: Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for, x-ws-collect-type,requestFromZITag,unifiedScriptVerified,_zitok
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

GET
H/1.1 200
OK events.js Show response
tags.srv.stackadapt.com/ 17 KB
6 KB 423ms
110ms Script
text/javascript 3.219.162.91
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://tags.srv.stackadapt.com/events.js
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.219.162.91 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-219-162-91.compute-1.amazonaws.com
Software: /
Resource Hash: 7452cc2bd0b90c58ba764c60fc4a8cac1d589110706aac0a91870729b450803e

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Access-Control-Allow-Origin: *
Date: Sun, 26 Mar 2023 16:10:33 GMT
Cache-Control: max-age=5
Content-Encoding: gzip
Connection: keep-alive
Content-Length: 5405
Content-Type: text/javascript

GET
H/1.1 200
OK rm_analytics.min.js Show response
assets.rampmetrics.com/code/ 38 KB
38 KB 245ms
9ms Script
text/javascript 13.32.121.18
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.rampmetrics.com/code/rm_analytics.min.js
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 13.32.121.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-13-32-121-18.fra60.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 93c6179beeeac217e3e27880170862a02833957c29a99f6a02f562113ed93319

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Date: Sun, 26 Mar 2023 01:16:22 GMT
Via: 1.1 06a27d66e25d02ebcfb014b9d194016a.cloudfront.net (CloudFront)
Last-Modified: Tue, 16 Mar 2021 17:17:43 GMT
Server: AmazonS3
X-Amz-Cf-Pop: FRA60-P1
Age: 53652
ETag: "d66a224f1230ed4958f1456dce053f73"
X-Cache: Hit from cloudfront
Content-Type: text/javascript
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 38718
X-Amz-Cf-Id: PFB4FFPU9RiQfM3lUZAcbCyxFC8__D_kH-XnJDl9Yh8JtmTHKxkIlg==

GET
H2 200 lftracker_v1_DzLR5a5QGmDaBoQ2.js Show response
sc.lfeeder.com/ 31 KB
11 KB 88ms
7ms Script
application/javascript 2600:9000:225e:3c00:1f:f723:6fc0:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://sc.lfeeder.com/lftracker_v1_DzLR5a5QGmDaBoQ2.js
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:225e:3c00:1f:f723:6fc0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 11db6ab47e0e8a319baf55282f38a6209f60adf5bb274094e69af824bd2da5b4

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-amz-version-id: yeZhHbCsTO4SH0Dmf7RYvbtFrsqy_0RX
content-encoding: gzip
via: 1.1 78280b924a7a9f0f018abcebd8ad82d0.cloudfront.net (CloudFront)
date: Sun, 26 Mar 2023 15:11:12 GMT
last-modified: Tue, 21 Mar 2023 07:40:00 GMT
server: AmazonS3
x-amz-cf-pop: FRA60-P4
age: 3562
etag: W/"a247fd0bc333f212a6d703216a6760b5"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
cache-control: max-age=3600
x-amz-cf-id: E-Ses3UCX7rfoBFWMVu1KxMiLq_EsuzZ74DL2Wow6VFDz3TsxBsI9Q==

POST
H2 200 collect Show response
www.google-analytics.com/j/ 4 B
213 B 17ms
16ms XHR
text/plain 2a00:1450:4001:810::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/j/collect?v=1&_v=j99&a=1540074268&t=pageview&_s=1&dl=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&ul=en-us&de=UTF-8&dt=FDA%20Drug%20Approvals%20in%202022%20%7C%20Visible%20Alpha&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEBAAEABAAAAACAAI~&jid=207190698&gjid=1700221541&cid=1567831358.1679847033&tid=UA-85798455-1&_gid=147709543.1679847033&_r=1&_slc=1&gtm=45He33m0n81P7WQNK9&z=1021263335

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
date: Sun, 26 Mar 2023 16:10:33 GMT
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://blog.visiblealpha.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 4
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 adsct
t.co/i/ 43 B
378 B 205ms
140ms Image
image/gif 104.244.42.133
TWITTER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://t.co/i/adsct?bci=3&eci=2&event_id=8197a1de-1249-4853-a925-57b617497c4b&events=%5B%5B%22pageview%22%2C%7B%7D%5D%5D&integration=advertiser&p_id=Twitter&p_user_id=0&pl_id=eda0a5e3-c477-4f21-a9f9-e5e941110e56&tw_document_href=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&tw_iframe_status=0&tw_order_quantity=0&tw_sale_amount=0&txn_id=o2kfp&type=javascript&version=2.3.29

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.244.42.133 , United States, ASN13414 (TWITTER, US),

Reverse DNS

Software

tsa_o /

Resource Hash

ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957

Security Headers

Name	Value
Strict-Transport-Security	max-age=0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-response-time: 111
date: Sun, 26 Mar 2023 16:10:33 GMT
strict-transport-security: max-age=0
server: tsa_o
content-type: image/gif;charset=utf-8
x-transaction-id: 6b8325caadf339fd
cache-control: no-cache, no-store, max-age=0
perf: 7626143928
x-connection-hash: db195af4d7d14b144969479adbcf2e602be95fc62a39e4826aeab835888a05cc
content-length: 43

GET
H2 200 adsct
analytics.twitter.com/i/ 43 B
395 B 204ms
142ms Image
image/gif 104.244.42.3
TWITTER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://analytics.twitter.com/i/adsct?bci=3&eci=2&event_id=8197a1de-1249-4853-a925-57b617497c4b&events=%5B%5B%22pageview%22%2C%7B%7D%5D%5D&integration=advertiser&p_id=Twitter&p_user_id=0&pl_id=eda0a5e3-c477-4f21-a9f9-e5e941110e56&tw_document_href=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&tw_iframe_status=0&tw_order_quantity=0&tw_sale_amount=0&txn_id=o2kfp&type=javascript&version=2.3.29

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.244.42.3 , United States, ASN13414 (TWITTER, US),

Reverse DNS

Software

tsa_o /

Resource Hash

ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957

Security Headers

Name	Value
Strict-Transport-Security	max-age=631138519

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-response-time: 112
date: Sun, 26 Mar 2023 16:10:32 GMT
strict-transport-security: max-age=631138519
server: tsa_o
content-type: image/gif;charset=utf-8
x-transaction-id: 53bf96b780b2ece7
cache-control: no-cache, no-store, max-age=0
perf: 7626143928
x-connection-hash: c616d8db83cf6b0fd6c24e4ddf4f86fd8bbfc377513dcc74e2c702bb20ac8347
content-length: 43

GET
H2 200 /
tr-rc.lfeeder.com/ 43 B
294 B 57ms
28ms Image
image/gif 13.32.99.98
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://tr-rc.lfeeder.com/?sid=DzLR5a5QGmDaBoQ2&data=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
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 13.32.99.98 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-13-32-99-98.fra60.r.cloudfront.net
Software: CloudFront /
Resource Hash: b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
via: 1.1 c43915e0cad14ee7685e5f74a99ce93c.cloudfront.net (CloudFront)
server: CloudFront
x-amz-cf-pop: FRA60-P3
x-cache: LambdaGeneratedResponse from cloudfront
content-type: image/gif
content-length: 43
x-amz-cf-id: cg3l_SSybt-2yC-qLV8e-Jbv-k5ydp8mV2ehxLyxvJTHMddKYdIGpQ==

POST
H2 200 collect Show response
stats.g.doubleclick.net/j/ 4 B
353 B 64ms
23ms XHR
text/plain 2a00:1450:400c:c07::9d
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j99&tid=UA-85798455-1&cid=1567831358.1679847033&jid=207190698&gjid=1700221541&_gid=147709543.1679847033&_u=YEBAAEAAAAAAACAAI~&z=707934342

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:400c:c07::9d Brussels, Belgium, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36
Content-Type: text/plain

Response headers

pragma: no-cache
strict-transport-security: max-age=10886400; includeSubDomains; preload
date: Sun, 26 Mar 2023 16:10:33 GMT
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://blog.visiblealpha.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 4
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/546794/domain/blog.visiblealpha.com/ 36 B
368 B 261ms
165ms XHR
application/json 2600:9000:20eb:f200:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/546794/domain/blog.visiblealpha.com/token
Requested by: Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.min.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:20eb:f200:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
content-encoding: gzip
via: 1.1 5a5b94c62ea85e0c0d78b169589b08b4.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA2-C1
vary: accept-encoding
x-cache: Miss from cloudfront
content-type: application/json
access-control-allow-origin: *
cache-control: public, max-age=3600
x-amz-cf-id: wdQxGk5SrzafqxvrqUb-Dga9QgMaUyzbeMQObnyh58onO0W4KMQ-Vw==

GET
H2

200

collect
px4.ads.linkedin.com/
Redirect Chain

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D546794%26time%3D1679847033443%26url%3Dhttps%253A%252F%252Fblog.visiblealpha.com%2...
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&liSync=true
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&liSync=true&e_i...

0
263 B

153ms
105ms

Image
application/javascript

13.107.42.14
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&liSync=true&e_ipv6=AQL6jV7sXzTNpQAAAYcer4uuE_YogXv-KCqyC9vAUc2Q9N45SXB_hApDIJ7aAiGGGDXMqoDXohYWwe-tBhndG4dee7DGWQ
Requested by: Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
Protocol: H2
Server: 13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
x-li-pop: afd-prod-lva1-x
x-msedge-ref: Ref A: C81C242A09304D9FB047F0192883D169 Ref B: FRAEDGE1215 Ref C: 2023-03-26T16:10:33Z
linkedin-action: 1
x-cache: CONFIG_NOCACHE
content-type: application/javascript
x-li-fabric: prod-lva1
x-li-proto: http/2
content-length: 0
x-li-uuid: AAX3z927002byRHHZAKrpg==

Redirect headers

date: Sun, 26 Mar 2023 16:10:33 GMT
x-li-pop: afd-prod-lva1-x
x-msedge-ref: Ref A: 2D2E0742F6874303B4367E449C797EE6 Ref B: FRAEDGE2021 Ref C: 2023-03-26T16:10:33Z
linkedin-action: 1
x-cache: CONFIG_NOCACHE
x-li-fabric: prod-lva1
location: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=546794&time=1679847033443&url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&liSync=true&e_ipv6=AQL6jV7sXzTNpQAAAYcer4uuE_YogXv-KCqyC9vAUc2Q9N45SXB_hApDIJ7aAiGGGDXMqoDXohYWwe-tBhndG4dee7DGWQ
x-li-proto: http/2
content-length: 0
x-li-uuid: AAX3z925gtQ0EqtlCnQuhA==

POST
H3 200 collect Show response
ws.zoominfo.com/pixel/ 0
596 B 151ms
150ms XHR
text/plain 2606:4700::6810:a852
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://ws.zoominfo.com/pixel/collect

Requested by

Host: ws.zoominfo.com
URL: https://ws.zoominfo.com/pixel/PX6eqp8JJGAXWkAuKxge

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700::6810:a852 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare / Express

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

requestFromZITag: false
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
x-ws-collect-type: xhr
unifiedScriptVerified: null
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36
Content-type: application/json; charset=UTF-8

Response headers

date: Sun, 26 Mar 2023 16:10:33 GMT
via: 1.1 google
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
server: cloudflare
x-powered-by: Express
access-control-allow-origin: https://blog.visiblealpha.com
access-control-allow-credentials: true
cf-ray: 7ae0aa186c222c42-FRA
access-control-allow-headers: Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for, x-ws-collect-type,requestFromZITag,unifiedScriptVerified,_zitok
content-length: 0
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

OPTIONS
H3 200 collect
ws.zoominfo.com/pixel/ Frame 0
0 160ms
147ms Preflight
text/html 2606:4700::6810:a852
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://ws.zoominfo.com/pixel/collect

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700::6810:a852 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare / Express

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Accept: */*
Access-Control-Request-Headers: content-type,requestfromzitag,unifiedscriptverified,x-ws-collect-type
Access-Control-Request-Method: POST
Origin: https://blog.visiblealpha.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

access-control-allow-credentials: true
access-control-allow-headers: Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for,x-ws-collect-type,requestFromZITag,unifiedScriptVerified,_zitok
access-control-allow-origin: https://blog.visiblealpha.com
allow: GET,HEAD,POST
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
cf-cache-status: DYNAMIC
cf-ray: 7ae0aa177a902c42-FRA
content-encoding: gzip
content-type: text/html; charset=utf-8
date: Sun, 26 Mar 2023 16:10:33 GMT
server: cloudflare
via: 1.1 google
x-content-type-options: nosniff
x-powered-by: Express

GET
H2 200 ga-audiences
www.google.com/ads/ 42 B
408 B 85ms
45ms Image
image/gif 2a00:1450:4001:813::2004
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j99&tid=UA-85798455-1&cid=1567831358.1679847033&jid=207190698&_u=YEBAAEAAAAAAACAAI~&z=1989677171

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:813::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

pragma: no-cache
date: Sun, 26 Mar 2023 16:10:33 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ga-audiences
www.google.de/ads/ 42 B
408 B 84ms
44ms Image
image/gif 2a00:1450:4001:80b::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j99&tid=UA-85798455-1&cid=1567831358.1679847033&jid=207190698&_u=YEBAAEAAAAAAACAAI~&z=1989677171

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

pragma: no-cache
date: Sun, 26 Mar 2023 16:10:33 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H/1.1 200
OK sa.css
tags.srv.stackadapt.com/ 65 B
292 B 98ms
97ms Stylesheet
text/css 3.219.162.91
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://tags.srv.stackadapt.com/sa.css
Requested by: Host: tags.srv.stackadapt.com
URL: https://tags.srv.stackadapt.com/events.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.219.162.91 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-219-162-91.compute-1.amazonaws.com
Software: /
Resource Hash: 58655895d2bfafc12b0c41b85cd0dbe9d3a339717f9c4475d762deecdedfe6ad

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Access-Control-Allow-Origin: *
Date: Sun, 26 Mar 2023 16:10:33 GMT
Cache-Control: only-if-cached, no-transform, private, max-age=7776000
Connection: keep-alive
Content-Length: 65
Content-Type: text/css

GET
H/1.1 200
OK sa.jpeg Show response
tags.srv.stackadapt.com/ 0
881 B 394ms
100ms Fetch
image/jpeg 3.219.162.91
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://tags.srv.stackadapt.com/sa.jpeg
Requested by: Host: tags.srv.stackadapt.com
URL: https://tags.srv.stackadapt.com/events.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.219.162.91 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-219-162-91.compute-1.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Access-Control-Allow-Origin: *
Date: Sun, 26 Mar 2023 16:10:34 GMT
Cache-Control: only-if-cached, no-transform, private, max-age=7776000
Connection: keep-alive
Content-Length: 651
Content-Type: image/jpeg

OPTIONS
H/1.1 200
OK RaXQsUSbW2qtDuzRyyfs
events.rm-api.com/v1/events/ Frame 0
0 343ms
99ms Preflight 52.202.168.65
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://events.rm-api.com/v1/events/RaXQsUSbW2qtDuzRyyfs
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 52.202.168.65 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-202-168-65.compute-1.amazonaws.com
Software: Cowboy /
Resource Hash

Request headers

Accept: */*
Access-Control-Request-Headers: content-type
Access-Control-Request-Method: POST
Origin: https://blog.visiblealpha.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Access-Control-Allow-Credentials: true
Access-Control-Allow-Headers: content-type
Access-Control-Allow-Methods: GET,HEAD,PUT,PATCH,POST,DELETE
Access-Control-Allow-Origin: https://blog.visiblealpha.com
Connection: keep-alive
Content-Length: 0
Date: Sun, 26 Mar 2023 16:10:34 GMT
Server: Cowboy
Vary: Origin, Access-Control-Request-Headers
Via: 1.1 vegur

GET
H2 200 __ptq.gif
track.hubspot.com/ 45 B
408 B 156ms
146ms Image
image/gif 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://track.hubspot.com/__ptq.gif?k=1&sd=1600x1200&cd=24-bit&cs=UTF-8&ln=en-us&bfp=828663872&v=1.1&a=2355593&pi=106512198193&ct=blog-post&ccu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&cpi=106512198193&cgi=4226313608&lpi=106512198193&lvi=106512198193&lvc=en-us&pu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&t=FDA+Drug+Approvals+in+2022+%7C+Visible+Alpha&cts=1679847033984&vi=3fe9c513beadbefc2cfbe4797a0f8fbe&nc=true&u=126586130.3fe9c513beadbefc2cfbe4797a0f8fbe.1679847033979.1679847033979.1679847033979.1&b=126586130.1.1679847033979&pt=0&cc=15

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc111a70984a9eda00752b06277113029ef288f1125c31eff2477413e15e8aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: be65d74e-4d54-43f7-a09f-a7fd44fdf4f4
p3p: CP="NOI CUR ADM OUR NOR STA NID"
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 45
server: cloudflare
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nZMqSlAWEL8HM4yaXsJX81QY6Ym46drTr7Ef2VECbeuuUFEUdHDK3mnfKYF%2F4Jl8D%2BsLO5BFPujZNIup6JCyDZs00T4KV%2Bgkc154Acp3OgAA2jPQPm8bYT4knxK3RlGpiziIjXsLFXLWYoea8DtE"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: no-cache, no-store, no-transform
access-control-allow-credentials: false
cf-ray: 7ae0aa1a9e0fbbfd-FRA
x-robots-tag: none

GET
H3 200 counters.gif
perf.hsforms.com/embed/v3/ 35 B
434 B 137ms
125ms Image
image/gif 2606:4700::6810:5705
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://perf.hsforms.com/embed/v3/counters.gif?key=cta-with-analytics&value=1

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700::6810:5705 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: MISS
x-hubspot-correlation-id: f89afedd-1272-45b4-a1ff-95c4435000ef
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 35
last-modified: Sun, 26 Mar 2023 16:10:34 GMT
server: cloudflare
x-trace: 2B97FF4960BA61D048E49913BAA8C5043449EB2D21000000000000000000
vary: origin, Accept-Encoding
content-type: image/gif
access-control-expose-headers: X-Origin-Hublet
cache-control: max-age=0, no-cache, no-store
access-control-allow-credentials: false
accept-ranges: bytes
x-robots-tag: none
cf-ray: 7ae0aa1a9d02364d-FRA

GET
H2 200 __pto.gif
track.hubspot.com/ 45 B
460 B 145ms
136ms Image
image/gif 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://track.hubspot.com/__pto.gif?w=1679847033985&m=ReferenceError%3A+hasVars+is+not+defined&j=1.1&n=ReferenceError&x=ReferenceError%3A+hasVars+is+not+defined%0A++++at+https%3A%2F%2Fblog.visiblealpha.com%2Fhs%2Fcta%2Fcta%2Fcurrent.js%3A1%3A1564%0A++++at+i+(https%3A%2F%2Fjs.hs-analytics.net%2Fanalytics%2F1679847000000%2F2355593.js%3A22%3A43464)%0A++++at+hstc.tracking.Runner.processHsq+(https%3A%2F%2Fjs.hs-analytics.net%2Fanalytics%2F1679847000000%2F2355593.js%3A22%3A44210)%0A++++at+hstc.tracking.Runner.run+(https%3A%2F%2Fjs.hs-analytics.net%2Fanalytics%2F1679847000000%2F2355593.js%3A22%3A43408)%0A++++at+i+(https%3A%2F%2Fjs.hs-analytics.net%2Fanalytics%2F1679847000000%2F2355593.js%3A22%3A65462)

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc111a70984a9eda00752b06277113029ef288f1125c31eff2477413e15e8aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: 2a0f98c4-8a5e-4783-b956-548775689335
p3p: CP="NOI CUR ADM OUR NOR STA NID"
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 45
server: cloudflare
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RFHoXFsUPnAB8hE8GtgUFcwC2IwXDI3K1P%2BH%2FVpzxuXB2bBNszQecQhnGJ2XLaYZYRqMYWkPMVXzgzHSgvdIVkWhWhTiW36Ra4ARLVuD1j3UNmkvwlT%2BIpbca15ly77KdAFOoQTzqHB8ZJWm3YIF"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: no-cache, no-store, no-transform
access-control-allow-credentials: false
cf-ray: 7ae0aa1a9e11bbfd-FRA
x-robots-tag: none

GET
H2 200 __ptq.gif
track.hubspot.com/ 45 B
462 B 141ms
140ms Image
image/gif 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://track.hubspot.com/__ptq.gif?k=15&fi=57098b06-4f8f-4c07-a61a-bf90a0b619cb&fci=1f10e7af-f648-46aa-a746-c4b3db7ba4af&ft=0&sd=1600x1200&cd=24-bit&cs=UTF-8&ln=en-us&bfp=828663872&v=1.1&a=2355593&pi=106512198193&ct=blog-post&ccu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&cpi=106512198193&cgi=4226313608&lpi=106512198193&lvi=106512198193&lvc=en-us&pu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&t=FDA+Drug+Approvals+in+2022+%7C+Visible+Alpha&cts=1679847033986&vi=3fe9c513beadbefc2cfbe4797a0f8fbe&nc=true&u=126586130.3fe9c513beadbefc2cfbe4797a0f8fbe.1679847033979.1679847033979.1679847033979.1&b=126586130.1.1679847033979&pt=0&cc=15

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc111a70984a9eda00752b06277113029ef288f1125c31eff2477413e15e8aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: fefbd951-1d94-4e2d-adbf-bfda9aa008e5
p3p: CP="NOI CUR ADM OUR NOR STA NID"
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 45
server: cloudflare
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=dR4u9bVDj3Dhg7WqtyN1JyFK92XEM7ZXPq4cYi4PJ6LXKQuW5RD5jnfi0ixaZ41aCZi7c2jnRdlKA0LGq%2FKMLUdm%2Bpp8UHCzjZleHcq5lJ2Bu9GIIBaQ3QxFBsenM1rI%2BQxLeP2untyv6HnP6bRX"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: no-cache, no-store, no-transform
access-control-allow-credentials: false
cf-ray: 7ae0aa1a9e1dbbfd-FRA
x-robots-tag: none

GET
H2 200 __ptq.gif
track.hubspot.com/ 45 B
380 B 139ms
138ms Image
image/gif 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://track.hubspot.com/__ptq.gif?k=17&fi=57098b06-4f8f-4c07-a61a-bf90a0b619cb&fci=1f10e7af-f648-46aa-a746-c4b3db7ba4af&ft=0&sd=1600x1200&cd=24-bit&cs=UTF-8&ln=en-us&bfp=828663872&v=1.1&a=2355593&pi=106512198193&ct=blog-post&ccu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&cpi=106512198193&cgi=4226313608&lpi=106512198193&lvi=106512198193&lvc=en-us&pu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&t=FDA+Drug+Approvals+in+2022+%7C+Visible+Alpha&cts=1679847033987&vi=3fe9c513beadbefc2cfbe4797a0f8fbe&nc=true&u=126586130.3fe9c513beadbefc2cfbe4797a0f8fbe.1679847033979.1679847033979.1679847033979.1&b=126586130.1.1679847033979&pt=0&cc=15

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc111a70984a9eda00752b06277113029ef288f1125c31eff2477413e15e8aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: 57afe618-d8c1-4b9e-a0a9-91562e6732fd
p3p: CP="NOI CUR ADM OUR NOR STA NID"
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 45
server: cloudflare
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=mTOruDTPAAv0AQbyOCeWRtmj7Ta1tWeI28hBHPW2WU%2F8vQEAQIathG%2BRE75KPlAX0BXmvh%2F6W%2B2bvGk3MAVUC%2FHjUEthe8xYAN80h4lkDHEny%2B3%2B2SzF1IDafwWUcC%2ByFEy537k73vS4xp5ICfku"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: no-cache, no-store, no-transform
access-control-allow-credentials: false
cf-ray: 7ae0aa1a9e20bbfd-FRA
x-robots-tag: none

GET
H2 200 __ptq.gif
track.hubspot.com/ 45 B
367 B 153ms
152ms Image
image/gif 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://track.hubspot.com/__ptq.gif?k=12&aij=%5B%228694811b-cee5-48c6-878f-b29131776884%22%2C%226943897d-5790-4aaa-9f0f-30abb000d0ee%22%5D&rfc=8&sd=1600x1200&cd=24-bit&cs=UTF-8&ln=en-us&bfp=828663872&v=1.1&a=2355593&pi=106512198193&ct=blog-post&ccu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&cpi=106512198193&cgi=4226313608&lpi=106512198193&lvi=106512198193&lvc=en-us&pu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&t=FDA+Drug+Approvals+in+2022+%7C+Visible+Alpha&cts=1679847033995&vi=3fe9c513beadbefc2cfbe4797a0f8fbe&nc=true&u=126586130.3fe9c513beadbefc2cfbe4797a0f8fbe.1679847033979.1679847033979.1679847033979.1&b=126586130.1.1679847033979&pt=0&cc=15

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc111a70984a9eda00752b06277113029ef288f1125c31eff2477413e15e8aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: b539e96c-bbfb-4f3c-8ef3-6a1a65ae6781
p3p: CP="NOI CUR ADM OUR NOR STA NID"
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 45
server: cloudflare
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=P6v81GC3etwCTxcxu%2FiQEq%2BCUdi0sOEdHrWaAL%2FarSuTKcjY%2BuHS8HIVXm095eQS9%2B4%2BZ34VVpXqheE2U6iUcKy%2FAIH32z4vW%2FmkSkHZB%2BbNhXuQeA2K%2FMGjfb5ol2RA%2FYKvRIbPGa5aYRsaj0J6"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: no-cache, no-store, no-transform
access-control-allow-credentials: false
cf-ray: 7ae0aa1a9e24bbfd-FRA
x-robots-tag: none

POST
H/1.1 200
OK RaXQsUSbW2qtDuzRyyfs Show response
events.rm-api.com/v1/events/ 30 B
327 B 311ms
105ms XHR
application/json 52.202.168.65
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://events.rm-api.com/v1/events/RaXQsUSbW2qtDuzRyyfs
Requested by: Host: assets.rampmetrics.com
URL: https://assets.rampmetrics.com/code/rm_analytics.min.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 52.202.168.65 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-52-202-168-65.compute-1.amazonaws.com
Software: Cowboy /
Resource Hash: bf2b1ee47306661a4153504cd92ffd453427febb9d9f26405d7809361f7c6b8b

Request headers

Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36
Content-Type: application/json

Response headers

Date: Sun, 26 Mar 2023 16:10:34 GMT
Via: 1.1 vegur
Server: Cowboy
Vary: Origin
Transfer-Encoding: chunked
Content-Type: application/json
Access-Control-Allow-Origin: https://blog.visiblealpha.com
Access-Control-Allow-Credentials: true
Connection: keep-alive

GET
H2 200 json Show response
forms.hubspot.com/lead-flows-config/v1/config/ 3 KB
2 KB 175ms
147ms XHR
application/json 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://forms.hubspot.com/lead-flows-config/v1/config/json?portalId=2355593&utk=3fe9c513beadbefc2cfbe4797a0f8fbe&__hstc=126586130.3fe9c513beadbefc2cfbe4797a0f8fbe.1679847033979.1679847033979.1679847033979.1&__hssc=126586130.1.1679847033979&contentId=106512198193&currentUrl=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making

Requested by

Host: js.hsleadflows.net
URL: https://js.hsleadflows.net/leadflows.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

7c5bc9e4ab03e4788f98054a00b66e4dbd917d426d068ef3bee8d0960454fc42

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: br
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: 94955381-9788-4cc1-842c-0326c9caf46e
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
server: cloudflare
vary: origin
access-control-allow-methods: GET, OPTIONS, PUT, POST, DELETE, PATCH, HEAD
content-type: application/json;charset=utf-8
access-control-allow-origin: https://blog.visiblealpha.com
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=WnOePaybV%2BWKECLgXyky2lTi111SxVtCxI8Td%2BM3FQJ0QQiyxusdO8fPNs8uhXS7wxrpHjAUamCf2zNZ52V2qQ7yfES%2Fw4%2BDylmGa1GnhFSkErd9NRvswrXQFDGFi1yQHLunSkIIun0VcuASW6PL"}],"group":"cf-nel","max_age":604800}
access-control-max-age: 180
access-control-allow-credentials: false
cache-control: max-age=0, no-cache, no-store
x-robots-tag: none
access-control-allow-headers: Accept, Accept-Charset, Accept-Encoding, Accept-Language, Content-Type, Host, Origin, Referer, User-Agent
cf-ray: 7ae0aa1ade749274-FRA

GET
H/1.1 200
OK saq_pxl Show response
tags.srv.stackadapt.com/ 160 B
470 B 98ms
97ms XHR
text/plain 3.219.162.91
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://tags.srv.stackadapt.com/saq_pxl?uid=aOPON9XH37lumH2X_W1TTQ&is_js=true&landing_url=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&t=FDA%20Drug%20Approvals%20in%202022%20%7C%20Visible%20Alpha&tip=Q8lychpmlK-Wfcjn3_3BfTE6l-Cx-UK5iZv1VUtMLHg&host=https://blog.visiblealpha.com&sa_conv_data_css_value=%20%220-773d1981-dab5-51fa-5ca6-1219b1bafdcf%22&sa_conv_data_image_value=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&sa-user-id-v2=s%253Adz0Zgdq1UfpcphIZsbr9z9lAlwk.ZUfIHXdbA2tccXY32baHj%252FeaTRXnK5uTC5GP%252FMNYiwU&sa-user-id=s%253A0-773d1981-dab5-51fa-5ca6-1219b1bafdcf.i8KVgC6TV33Z7EAA%252FtPVEhQdbGhCm60OT5kvSzx0W1g
Requested by: Host: tags.srv.stackadapt.com
URL: https://tags.srv.stackadapt.com/events.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.219.162.91 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-3-219-162-91.compute-1.amazonaws.com
Software: /
Resource Hash: 01cd8fca194e4bbca2d24762438c585cb29479724ccdf09e0b3a63c97ab04555

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

Date: Sun, 26 Mar 2023 16:10:34 GMT
Access-Control-Allow-Methods: GET
Content-Type: text/plain; charset=utf-8
Access-Control-Allow-Origin: https://blog.visiblealpha.com
Access-Control-Allow-Credentials: true
Connection: keep-alive
Access-Control-Allow-Headers: *
Content-Length: 160

GET
H2 200 __ptq.gif
track.hubspot.com/ 45 B
360 B 135ms
135ms Image
image/gif 2606:4700::6813:9b53
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://track.hubspot.com/__ptq.gif?k=16&fi=51de6860-766f-496f-b69e-2392db239a07&lfi=4479766&ft=1&sd=1600x1200&cd=24-bit&cs=UTF-8&ln=en-us&bfp=828663872&v=1.1&a=2355593&pi=106512198193&ct=blog-post&ccu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&cpi=106512198193&cgi=4226313608&lpi=106512198193&lvi=106512198193&lvc=en-us&pu=https%3A%2F%2Fblog.visiblealpha.com%2Ffda-drug-approvals-in-2022-several-blockbusters-in-the-making&t=FDA+Drug+Approvals+in+2022+%7C+Visible+Alpha&cts=1679847034205&vi=3fe9c513beadbefc2cfbe4797a0f8fbe&nc=true&u=126586130.3fe9c513beadbefc2cfbe4797a0f8fbe.1679847033979.1679847033979.1679847033979.1&b=126586130.1.1679847033979&pt=0&cc=15

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6813:9b53 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc111a70984a9eda00752b06277113029ef288f1125c31eff2477413e15e8aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

date: Sun, 26 Mar 2023 16:10:34 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: 4a3e86bf-7f73-4fe0-87d4-f397bf8dfe8b
p3p: CP="NOI CUR ADM OUR NOR STA NID"
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 45
server: cloudflare
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qBe4Byf9w2lgZ9SfFk6I9CrIRWITd7FY0xcP3mwwL38W%2FJviQejOzm228ScTxZn%2BzflGuZLANfSHdxorNZPSuUSfuZSbCQpgUL%2B0cLmtgksjc6rWNiHSRrKXZVREw4ShEF%2BRPvdG2GvVCcXR2sAp"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: no-cache, no-store, no-transform
access-control-allow-credentials: false
cf-ray: 7ae0aa1bd84ebbfd-FRA
x-robots-tag: none

GET
H2 200 va-retail-ebook-cover2B.jpg
2355593.fs1.hubspotusercontent-na1.net/hubfs/2355593/ 240 KB
241 KB 43ms
43ms Image
image/webp 2606:4700:4400::ac40:9ad8
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://2355593.fs1.hubspotusercontent-na1.net/hubfs/2355593/va-retail-ebook-cover2B.jpg
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:4400::ac40:9ad8 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 3c2fdb7b882a8fb639d7abd6437a9dda791e1e3bb63c3c8d0694553a624e5958

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36

Response headers

x-amz-meta-cache-tag: F-101744040980,P-2355593,FLS-ALL
age: 552702
x-amz-request-id: 2T0NTCFYDR34MJ6X
x-amz-server-side-encryption: AES256
edge-cache-tag: F-101744040980,P-2355593,FLS-ALL
x-amz-replication-status: COMPLETED
content-disposition: inline; filename="va-retail-ebook-cover2B.webp"
x-hs-cf-lambda: us-east-1.enforceAclForReadsProd 15
cf-bgj: imgq:85,h2pri
etag: "58c217a38f48a03ae1191d7d4d39bdce"
vary: Accept, Accept-Encoding
access-control-allow-methods: GET
content-type: image/webp
access-control-allow-origin: *
x-amz-meta-created-unix-time-millis: 1675895323630
cache-control: s-maxage=1814400, max-age=1209600, stale-while-revalidate=900
x-robots-tag: none
x-hs-cf-lambda-enforce: us-east-1.enforceAclForReadsProd 15
date: Sun, 26 Mar 2023 16:10:35 GMT
via: 1.1 15d56bef7b8d30c7328ed4685742279e.cloudfront.net (CloudFront)
cf-cache-status: HIT
x-amz-version-id: W.RQs0XzoHlzqxaEXExsEpTSwaNw7nnK
x-amz-cf-pop: IAD79-C3
x-hs-alternate-content-type: text/plain
cf-polished: qual=85, origFmt=jpeg, origSize=413477
x-cache: RefreshHit from cloudfront
cache-tag: F-101744040980,P-2355593,FLS-ALL
x-amz-meta-index-tag: none
x-amz-storage-class: INTELLIGENT_TIERING
content-length: 245598
x-amz-id-2: 51+Ro8apMF7hyQpDrvQfS5+CxbecpsZ88POsYpceIGajinhdxYRnJamM9iUBfNFcFqazsoXMQQM=
last-modified: Wed, 08 Feb 2023 22:28:44 GMT
server: cloudflare
accept-ranges: bytes
cf-ray: 7ae0aa2209bb39e5-FRA
x-amz-cf-id: 8V_NdLdpR5Qu-7BaOMROV7KWyB6ODncyIh_hHVOIQv7MbWgUm7M_IQ==

POST
H3 200 perf Show response
blog.visiblealpha.com/_hcms/ 2 B
604 B 153ms
152ms XHR
text/plain 2606:2c40::c73c:671c
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://blog.visiblealpha.com/_hcms/perf

Requested by

Host: blog.visiblealpha.com
URL: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:2c40::c73c:671c , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000

Request headers

Referer: https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/111.0.5563.110 Safari/537.36
Content-type: application/json

Response headers

date: Sun, 26 Mar 2023 16:10:37 GMT
strict-transport-security: max-age=31536000
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-hubspot-correlation-id: f576873e-9a39-4281-96f7-975ea2740d0d
x-hs-https-only: worker
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length: 2
server: cloudflare
x-trace: 2BD8ABBDF91A8926607496E92AF503E9D41828F5D1000000000000000000
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=S13r%2B%2FC5Yo9JXbcS60GoLnoX84CyXGpPVSwTkG5YApMGlSH%2BEvJZGdHmxQiLggJuCzkzBm%2Bmyj6vrCbyVPOsQCEM1WR2Y0RZ8yV28OLYoUqy09XaCYjfWAvQtzndAA7fVm9XgwcN6ecaIcShhc82QM0Wcw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/plain; charset=utf-8
access-control-allow-credentials: false
cf-ray: 7ae0aa2d2cba9a18-FRA
x-robots-tag: none

Verdicts & Comments Add Verdict or Comment

109 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

31 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
.blog.visiblealpha.com/	1970-01-20 10:37:28	Name: __cf_bm Value: 1RaHVNgCAEOUEihWyGf2G0z7YDO6.ecqrGJyrQ0VsI4-1679847032-0-AQzRZUqiLxq/hNDjcEtqnYmN7kk4lZfYPNKg7mjP/6320QELjQoWfG1tw+ldvfUb+OTLL8u+xnMJsArKGUM7bw0=
.blog.visiblealpha.com/	1969-12-31 23:59:59	Name: __cfruid Value: 7972680e1ee77b962a8634ec8e070df678026b5d-1679847032
.doubleclick.net/	1970-01-20 10:37:27	Name: test_cookie Value: CheckForPermission
.hubspot.com/	1970-01-20 10:37:28	Name: __cf_bm Value: ISjwlESJlu4HtYwvN8mCIDs2AwMm_8kkChfvYRM2kkk-1679847032-0-AYvvcWlrYz8JAuOZzbiKS0dcX1iSMtcWABpS5GHvMu0qRrgDnCjaVaHtMlCvO3LpsutSRix2HabxBjOW4TuR5y4=
.ws.zoominfo.com/	1970-01-20 19:23:03	Name: visitorId Value: cad1a59b1b7c2f1f0007c196c1104228d79190a04ad619109dd23594f898abcb
.zoominfo.com/	1970-01-20 10:37:28	Name: __cf_bm Value: 7LN6LQRCw0ikL.54c1hvArrlm9jqQM9Vivuzk6r_jxY-1679847032-0-AS+uTQlrVh9BTOEVbEe5nvpvuXHnnNSps3yJgkuni7+1QKZJ2ftgliQcFJWLjcNCgixXo6TTelM8KyKPFQHwEZo=
.zoominfo.com/	1969-12-31 23:59:59	Name: _cfuvid Value: NCaM3VU2lzuM59PmKWd0Dbdfi57IPELr7o8DOKsWQ7k-1679847032621-0-604800000
.visiblealpha.com/	1970-01-20 20:13:27	Name: _ga Value: GA1.2.1567831358.1679847033
.visiblealpha.com/	1970-01-20 10:38:53	Name: _gid Value: GA1.2.147709543.1679847033
.visiblealpha.com/	1970-01-20 10:37:27	Name: _gat_UA-85798455-1 Value: 1
.visiblealpha.com/	1970-01-20 20:13:27	Name: _lfa Value: LF1.1.fe32be652d21386f.1679847033437
.linkedin.com/	1970-01-20 11:20:39	Name: UserMatchHistory Value: AQKuFFDzvX6vrQAAAYcer4rRyCw0Mgmwn2YXB3Vn6Ver5US4U_wl1-sNfHU_1crZl6XUFQ61bnjccQ
.linkedin.com/	1970-01-20 11:20:39	Name: AnalyticsSyncHistory Value: AQJSdi1b-DGufwAAAYcer4rR-Raq5vM2nlnna5z9DRuGzZJmhTv1iOthXNr1xVtdwnDOIBTlONsakuyXBZlB2Q
.linkedin.com/	1970-01-20 19:23:03	Name: bcookie Value: "v=2&fae8f664-905f-4787-8054-ebe37bbda620"
.linkedin.com/	1970-01-20 10:38:53	Name: lidc Value: "b=VGST00:s=V:r=V:a=V:p=V:g=2956:u=1:x=1:i=1679847033:t=1679933433:v=2:sig=AQHG6-LM1qD4WhoeO9KcL3uSKYWNQaPS"
.twitter.com/	1970-01-20 20:13:27	Name: personalization_id Value: "v1_ZfiS3J9PcAAxFWAruq7xtw=="
.t.co/	1970-01-20 20:13:27	Name: muc_ads Value: 415347bc-5cc3-4e59-9f98-59ef481355c2
blog.visiblealpha.com/	1970-01-20 10:38:53	Name: ln_or Value: eyI1NDY3OTQiOiJkIn0%3D
.www.linkedin.com/	1970-01-20 19:23:03	Name: bscookie Value: "v=1&2023032616103398242c87-68d5-4652-86fc-4bec87fe953fAQHB6_mIYaSLf_duuB1pEWrbyRByP6f-"
.linkedin.com/	1970-01-20 14:56:39	Name: li_gc Value: MTswOzE2Nzk4NDcwMzM7MjswMjFPMYtP6Hzw8Fz3xISBhWr9xzKomAV8y5ZvEV8Phk1EJQ==
tags.srv.stackadapt.com/	1970-01-20 19:23:03	Name: sa-user-id Value: s%3A0-773d1981-dab5-51fa-5ca6-1219b1bafdcf.i8KVgC6TV33Z7EAA%2FtPVEhQdbGhCm60OT5kvSzx0W1g
tags.srv.stackadapt.com/	1970-01-20 19:23:03	Name: sa-user-id-v2 Value: s%3Adz0Zgdq1UfpcphIZsbr9z9lAlwk.ZUfIHXdbA2tccXY32baHj%2FeaTRXnK5uTC5GP%2FMNYiwU
.srv.stackadapt.com/	1970-01-20 19:23:03	Name: sa-user-id-v2 Value: s%3Adz0Zgdq1UfpcphIZsbr9z9lAlwk.ZUfIHXdbA2tccXY32baHj%2FeaTRXnK5uTC5GP%2FMNYiwU
blog.visiblealpha.com/	1970-01-20 19:23:03	Name: sa-user-id Value: s%253A0-773d1981-dab5-51fa-5ca6-1219b1bafdcf.i8KVgC6TV33Z7EAA%252FtPVEhQdbGhCm60OT5kvSzx0W1g
blog.visiblealpha.com/	1970-01-20 19:23:03	Name: sa-user-id-v2 Value: s%253Adz0Zgdq1UfpcphIZsbr9z9lAlwk.ZUfIHXdbA2tccXY32baHj%252FeaTRXnK5uTC5GP%252FMNYiwU
.visiblealpha.com/	1970-01-20 14:56:39	Name: __hstc Value: 126586130.3fe9c513beadbefc2cfbe4797a0f8fbe.1679847033979.1679847033979.1679847033979.1
.visiblealpha.com/	1970-01-20 14:56:39	Name: hubspotutk Value: 3fe9c513beadbefc2cfbe4797a0f8fbe
.visiblealpha.com/	1969-12-31 23:59:59	Name: __hssrc Value: 1
.visiblealpha.com/	1970-01-20 10:37:28	Name: __hssc Value: 126586130.1.1679847033979
.visiblealpha.com/	1970-01-20 19:23:03	Name: rm_RaXQsUSbW2qtDuzRyyfs Value: {%22$uid%22:%221871eaf8c9b-8fed711e-7651-4960-b6d9-44f52263ab52%22}
.visiblealpha.com/	1970-01-20 10:38:53	Name: _rm_dr Value: {%22referrer%22:%22%22%2C%22inbound%22:%22https://blog.visiblealpha.com/fda-drug-approvals-in-2022-several-blockbusters-in-the-making%22}

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Content-Security-Policy	upgrade-insecure-requests
Strict-Transport-Security	max-age=31536000

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

2355593.fs1.hubspotusercontent-na1.net
analytics.twitter.com
api-na1.hubapi.com
app.hubspot.com
assets.rampmetrics.com
blog.visiblealpha.com
cdn.jsdelivr.net
cdn.linkedin.oribi.io
cdn2.hubspot.net
cdnjs.cloudflare.com
cta-service-cms2.hubspot.com
events.rm-api.com
fonts.googleapis.com
fonts.gstatic.com
forms-na1.hsforms.com
forms.hsforms.com
forms.hubspot.com
js.hs-analytics.net
js.hs-banner.com
js.hsleadflows.net
no-cache.hubspot.com
perf.hsforms.com
platform.linkedin.com
platform.twitter.com
pubads.g.doubleclick.net
px.ads.linkedin.com
px4.ads.linkedin.com
sc.lfeeder.com
snap.licdn.com
stackpath.bootstrapcdn.com
static.ads-twitter.com
stats.g.doubleclick.net
syndication.twitter.com
t.co
tags.srv.stackadapt.com
tr-rc.lfeeder.com
track.hubspot.com
unpkg.com
ws.zoominfo.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.linkedin.com
104.244.42.133
104.244.42.200
104.244.42.3
13.107.42.14
13.32.121.18
13.32.99.98
146.75.116.157
2600:9000:20eb:f200:2:53b2:240:93a1
2600:9000:225e:3c00:1f:f723:6fc0:93a1
2606:2800:234:59:254c:406:2366:268c
2606:2c40::c73c:671c
2606:4700:4400::6812:21ab
2606:4700:4400::ac40:9ad8
2606:4700::6810:5605
2606:4700::6810:5705
2606:4700::6810:5714
2606:4700::6810:5805
2606:4700::6810:7daf
2606:4700::6810:a852
2606:4700::6811:180e
2606:4700::6811:47b0
2606:4700::6811:cccc
2606:4700::6811:eacc
2606:4700::6811:f4cc
2606:4700::6812:acf
2606:4700::6813:9b53
2620:1ec:21::14
2a00:1450:4001:806::2002
2a00:1450:4001:80b::2003
2a00:1450:4001:810::200e
2a00:1450:4001:811::2003
2a00:1450:4001:813::2004
2a00:1450:4001:813::2008
2a00:1450:4001:813::200a
2a00:1450:400c:c07::9d
2a02:26f0:480:e::210:f108
2a02:26f0:480:e::210:f113
3.219.162.91
52.202.168.65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blog.visiblealpha.com Open in urlscan Pro 2606:2c40::c73c:671c Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Detected technologies

Page Statistics

98 Requests

97 %HTTPS

77 %IPv6

31 Domains

44 Subdomains

38 IPs

3 Countries

3259 kBTransfer

5552 kBSize

31 Cookies

52 Outgoing links

Redirected requests

98 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 0 data transactions

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Redirect headers

Request headers

blog.visiblealpha.com Open in urlscan Pro
2606:2c40::c73c:671c Public Scan

Screenshot
Live screenshot

Full Image

98
Requests

97 %
HTTPS

77 %
IPv6

31
Domains

44
Subdomains

38
IPs

3
Countries

3259 kB
Transfer

5552 kB
Size

31
Cookies

98 HTTP transactions
0 data transactions